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Simmiary.
In this study induction of diabetes in CD^ mice using 
Coxsackie virus was attempted with a view to developing an ade­
quate animal model. However, in a series of three experiments no 
diabetic-like state was observed.
In clinical studies insulin-dependent diabetics (I.D.D.), in­
sulin-independent diabetics (I.I.D.), and control subjects were 
tested for leucocyte migration inhibition against pancreatic anti­
gens, Coxsackie B4 virus, and rat liver mitochondria. Inhibition of 
migration was observed more often against these antigens in the I.D.D. 
In another study of cell-mediated function lymphocytes from 10 I.D.D. 
were tested for PHA-induced transformation. Two patients showed de­
pression of this response compared to individual control responses.
An indirect immunofluorescence technique was used to assess 
the incidence of autoantibodies. In 54 I.D.D. islet cell antibodies 
were found in 32%, whilst there was a greater incidence of other 
autoahtibodies (thyroid, gastric parietal cell, antinuclear, reticu- 
lin, smooth muscle and mitochondrial) in the sera of this group com­
pared to I.I.D. and the control subjects. Preliminary absorption 
studies of islet cell antibody (ICA) positive sera from 4 I.D.D. 
incubated with Coxsackie B4 virus produced a decrease in intensity of 
fluorescence in 3 cases, whilst an increase in the intensity was 
observed in some cases when pancreatic homogenate, microsomes, and 
mitochondria were used.
HLA studies revealed a higher incidence of HLA-B8 and B15 in
I.D.D. with a protective effect conferred by HLA-B7. No correla­
tion was found between any HLA antigens and immune phenomena.
Finally, 13 I.D.D. were examined for T-cell cytotoxicity against 
chicken erythrocytes coated with pancreatic fractions, and 17 I.D.D. 
for antibody-dependent cell-mediated (K-cell) cytotoxicity. No . 
evidence of T-cell cytotoxicity was found, whilst 4/17 patients 
showed depression of K-cell activity by more than 10% when compared 
to control subjects.
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CHAPTER I.
Introduction.
Definition. Diabetes mellitus is,a chronic disease which, in the un­
controlled state, is manifested by multiple disturbances of metabolic 
processes which are attributable to an insufficient insulin supply.
The rate of utilisation of sugar declines and hyperglycaemia and gly­
cosuria ensue. As the loss of sugar increases, protein is broken down 
in an attempt to supply energy and muscle wasting becomes apparent.
In addition, there is a decrease in the synthesis of fat from carbo­
hydrate and an increase in fat catabolism which leads to the produc­
tion of ketones in excess of tissue utilisation. Eventually, without 
treatment, there is a massive build-up of ketones in the blood which 
leads to coma and finally death.
Complications. Complications arising from diabetes mellitus include 
retinopathy, neuropathy, nephropathy, and atherosclerosis. The life 
expectancy of the diabetic is thus reduced. In the diabetic popula­
tion the most common cause of death is heart disease or kidney dis­
ease. In the U.S.A. diabetes mellitus is the third most common cause 
of death behind dissociated heart disease and cancer . It is also a 
major cause of blindness, being the second most common cause in the 
U.S^.A. (Maugh, 1975).
Incidence, Diabetes mellitus is a common disease and has traditionally 
been divided into two forms, the maturity- and juvenile-onset types.
The majority of cases belong to the maturity-onset type. Baird and 
Strong (1975) quote the prevalence of diabetes as being 1% in the 
United Kingdom, but of these only 10% are juvenile-onset diabetics. 
Drash (1975) estimated that 1% of the adult population in the United 
States are diabetic, and that there are an equal number with chemical 
diabetes or asymptomatic glucose intolerance. He further states that 
diabetes occurs in approximately 1 of 2,500 children under fifteen 
years of age. Farquhar (1973) estimated the prevalence to be slightly 
lower in Britain with diabetes affecting approximately 35 of every 
100,000 children under the age of sixteen.
Steinke and Soeldner (1977) estimated that there are over 200
million diabetics in the world. This data, taken from the U.S.
Public Health Service, shows that for children up to the age of seven­
teen years there are 130 diabetics/1000,000 population, for people 
aged between 25-44 years, 1,700/100,000, and for people between 45-64 
years of age there are 4,300 diabetics per 100,000 population, whilst 
in the group over 60 years of age there are 7,900/100,000 population.
A 1975 survey of new diabetics in the United Kingdom between the
ages of 0-15 years revealed an annual incidence rate of 7.67/100,000 
(Bloom, Hayes, and Gamble, 1975). Mann, Thorogood, and Smith (1978) 
reported on new cases of juvenile-onset diabetes where development of 
the disease occurred before the age of sixteen years, and found the 
incidence ranged from 4.6/100,000 to 14.8/100,000 according to the 
district. Recent surveys in Denmark have revealed an incidence of 
13.2/100,000 per year for juvenile-onset diabetics aged between 0 and 
29 years (Cristau et al,, 1977) and an incidence of 11.3/100,000 in 
the Copenhagen area (Andersen et al., 1977).
The prevalence of diabetes mellitus varies considerably between 
populations. Thus, Bennett reports a prevalence of 30.6% in American
Pima Indians aged fifteen years or more, while the prevalence in 
Eskimos is reported to be low (Scott and Griffiths, 1957). A survey 
on the Central Pacific island of Nauru revealed a prevalence of 34.4% 
for maturity-onset diabetes (Zimmet et al., 1977), whilst juvenile 
diabetes is virtually unknown. Other population groups showing low 
prevalence of juvenile-onset diabetes include Indians and Negroes in 
Cape Town and Trinidad, Cook Island Maoris, Japanese, and Maltese 
(Keen and Jarrett, 1976). However, Keen and Jarrett (1976) point out 
that comparative prevalence studies have limited value where the dura­
tion of disease varies from group to group and that true incidence 
studies would be of more value.
Classification. Diabetes mellitus is usually divided into two forms, 
the juvenile-onset, insulin-dependent, ketosis prone type, and the 
maturity-onset, nonketotic form. The former is characterised by a 
severe insulin deficiency, whilst in the latter type insulin is pres­
ent, but its action or secretion is impaired, Sonksen (1972) con­
siders diabetes mellitus as a syndrome rather than as a specific dis­
ease. He divides clinical diabetes into acute or juvenile-onset and 
chronic or maturity-onset diabetes. Craighead (1975) states that the 
syndrome of diabetes mellitus may represent a complex of diseases hav­
ing several aetiologies and different forms of clinical expression. 
Other investigators classify diabetes mellitus in different ways. 
Irvine (1977) divides idiopathic diabetes mellitus into types I and 
II;
I. Insulin-dependent juvenile-onset.
Insulin-dependent maturity-onset.
Islet cell antibody-positive diabetics initially con­
trolled by oral hypoglycaemic agents but requiring insulin 
in later years.
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II. Insulin-independent juvenile-onset.
Insulin-independent maturity-onset.
Islet cell antibody negative at diagnosis.
He further subdivides type I according to pathogenesis:
(a) severe autoimmune/non-viral (rare).
(b) moderate autoimmune/moderate viral (common).
(c) severe viral/non-autoimmune (rare).
Cudworth and Woodrow (1977) regard type I as equivalent to juve­
nile-onset diabetes irrespective of age and showing a significant 
association with the major histocompatibility system, whereas type II 
corresponds to maturity-onset, insulin-independent diabetes and has no 
association with the major histocompatibility system. They question 
Irvine * s classification, pointing out that the use of oral hypogly­
caemic agents to middle-aged or elderly diabetics within three months 
of onset is probably meaningless in terms of pathogenesis of the two 
types of diabetes and is much more likely to reflect differences in 
clinical practice in the management of such patients. They also state 
that there is no evidence for the subgroups (b) and (c) of type I 
diabetes which are based upon those patients who show islet cell anti­
body for a limited period after diagnosis and those in whom anti­
bodies are not found. As there is uncertainty in the time lapse be­
tween the pathological event and diagnosis, the latter group may ini­
tially have had islet cell antibodies.
Bottazzo and Doniach (1976) divide type I diabetes mellitus into 
lA and IB, the lA subgroup being the classical juvenile-onset form 
with no associated autoimmune disorders and high titres of islet cell 
antibodies at the onset which tend to disappear with time. The IB 
subgroup is associated with well established autoimmune disorders and
a high incidence of other autoantibodies. In this type islet cell 
antibodies, when found, remain stable for several years. Bottazzo and 
Doniach’s (1976) separation of diabetes into types lA and IB is on the 
basis of whether islet cell antibodies are temporary and perhaps sec­
ondary to viral islet disease or permanent and associated with poly- 
endocrine disorders and HLA-B8. Type lA of this system corresponds 
to Ib of Irvine’s classification, although Bottazzo does not take into 
account diabetics initially treated with oral hypoglycaemic agents who 
are islet cell antibody positive.
In the present report the diabetic groups are divided into 
juvenile-onset, insulin-dependent diabetics independent of age of on­
set, and maturity-onset, insulin-independent diabetics. When com­
parisons are made with work presented by other -investigators, however, 
the juvenile-onset type diabetics may be subdivided according to age.
Aetiology and Pathogenesis. The aetiology of diabetes mellitus has 
been the subject of much speculation. Since viruses were originally 
suggested (Adams, 1926), a large number have been implicated. These 
include mumps, hepatitis, rubella, Coxsackie and influenza viruses, 
adenoviruses, enteroviruses, and cytomegalovirus (Maugh, 1975). The 
fact that many viruses have been shown to be diabetogenic in various 
animal species has lent support to the theory of a viral aetiology.
The viral implications of diabetes mellitus will be fully discussed 
in Chapter II.
Other environmental factors have also been suggested, such as 
diet. Thus, Trowell (1974) related the incidence of childhood dia­
betes to dietary factors and suggested that high fibre carbohydrate 
foods are protective against diabetes.
Recent studies of the HLA system have provided evidence for the 
existence of genetic heterogeneity in diabetes. Cudworth (1978) 
stated that, irrespective of age of onset, the major susceptibility to 
chemical insulin-dependent diabetes is conferred by genes in the HLA 
chromosomal region. Other genes outside the HLA region may also con­
tribute to overall susceptibility^ Thus, HLA-associated immune re­
sponse genes may affect susceptibility to environmental pathogens such 
as viruses. Furthermore, Cudworth (1978) has suggested that strong 
genetic factors, not associated with the HLA system, operate to pro­
duce susceptibility to maturity-onset, insulin-independent (type II) 
diabetes.
Immune response genes, possibly associated with the HLA system, 
might play a part in conferring susceptibility or protection to par­
ticular viruses which have an affinity for the islet cells of the 
pancreas (Notkins, 1977; Cudworth, 1978). The association of dia­
betes and the HLA system will be more fully discussed in Chapter 6.
For several years diabetes mellitus has been thought of as an 
autoimmune disease. Considerable evidence has been compiled in favor 
of this hypothesis:
1. An association with other autoimmune endocrinopathies 
(Irvine, 1970; Nerup and Binder, 1973; MacCuish et al., 
1974).
2. The presence of circulating autoantibodies to the gastric 
parietal cell, thyroid cytoplasm, and adrenal tissue 
(Nerup and Binder, 1973; MacCuish et al., 1974).
3. The presence of islet cell antibodies (Bottazzo, Flcrin- 
Christensen, and Doniach, 1974; MacCuish et al., 1974; 
Lendrum, Walker, and Gamble, 1975).
4. The presence of cell-mediated immunity to pancreatic 
antigens (Nerup et al., 1971, 1973; MacCuish et al.,
1974a; Richens, Hartog, and Ancill, 1976).
5. The induction of experimental diabetes in animals 
(Craighead and Steinke, 1971; Coleman et al., 1974).
6. The infiltration of the, pancreas by lymphocytes (Gepts,
1965; Junker et al., 1977).
7. The association with certain HLA antigens (Nerup et 
al., 1974; Cudworth and Woodrow, 1974, 1975, 1976;
Cudworth, 1978).
Irvine et al. (1970) found an increased frequency of circulat­
ing thyroid and gastric parietal cell antibodies in patients with 
diabetes mellitus. These antibodies were more frequently found in 
insulin-dependent diabetics than in insulin-independent diabetics.
Nerup and Binder (1973) confirmed Irvine’s work but were unable to find 
any difference between juvenile-onset and maturity-onset diabetics 
when the frequencies of autoantibodies were compared. They also 
found that the simultaneous occurrence of two or more autoantibodies 
to thyroid, adrenal cortex, or gastric parietal cell cytoplasm was 
seen only in the sera of diabetic patients.
According to Bottazzo et al. (1974) the prevalence of thyroid 
and gastric antibodies is three times greater in juvenile diabetics 
than in age and sex matched controls. The association of diabetes 
with autoimmune adrenalitis was investigated and Bottazzo et al. (1974) 
found that the incidence of overt diabetes in idiopathic Addison’s 
disease was approximately 10% as compared to 1% in the overall popu­
lation. They also reported that adrenal antibodies are found thirty 
times more often in insulin-dependent diabetics than in control
subjects. They additionally noted that the combination of adrenalitis 
and thyroiditis has been reported in association with insulin-dependent 
diabetes. Bottazzo et al. (1974) concluded that the presence of sev­
eral autoimmune disorders in the same patient indicates a strong 
hereditary predisposition to autoimmunity.
MacCuish et al. (1974) supported the presence of an autoimmune 
process in some cases of diabetes and quoted as evidence an associa­
tion between diabetes mellitus and other autoimmune disorders such as 
pernicious anaemia, thyrotoxicosis, Hashimoto’s thyroiditis, idio­
pathic hypoparathyroidism, and myasthenia gravis.
Islet cell antibodies were first detected by Bottazzo et al. 
in 1974 and they found an increased incidence in patients with dia­
betes mellitus. They were also found by MacCuish et al. (1974). Both 
groups of workers suggested that islet cell antibodies were confined 
to patients with one or more overt autoimmune diseases in addition to 
diabetes mellitus. However, Lendrum et al. (1975) found islet cell 
antibodies were more common in juvenile-onset diabetics of recent on­
set and suggested that autoimmune activity directed against islet 
cells was likely in a high proportion of cases of childhood diabetes. 
This idea is not compatible with the age distribution and seasonal 
variation found in juvenile diabetes, and these are unlikely to be the 
result of a purely immunologic pathogenesis. Lendrum et al. (1975) 
suggested that perhaps autoimmune damage in combination with a seasonal 
factor such as a virus was a more probable explanation,
MacLaren, Huang, and Fogh (1975), using human insulinoma cells, 
found a high incidence of antibodies showing cell surface immuno­
fluorescence in the sera of insulin-dependent diabetics. They were 
uncertain whether autoimmunity is of primary aetiological significance
and suggested that 3-cell damage, possibly by a virus, might expose 
sequestered 3-cell antigens and initiate an immune response as a sec­
ondary event.
Further evidence that diabetes mellitus has an autoimmune basis 
comes from reports of insulitis.lc and infiltration by lymphocytes of 
the islet cells at post-mortem of, diabetic children (Gepts, 1965; 
Junker et al., 1977) and a report by Le Compte and Legg (1972) of 
lymphocytic infiltration of the pancreatic islets in two insulin- 
dependent late onset diabetics. This, combined with lack of plasma 
cells and lymphoid follicle formation, is a feature of accepted organ- 
specific autoimmune disorders (Editorial, Lancet, 1976). However, 
Doniach and Morgan (1973) found no lymphocytic infiltration in 
thirteen young diabetics, whilst Maclean and Ogilvie (1959) reported 
only three cases out of twenty-two diabetics.
Delayed hypersensitivity as assessed by the leucocyte migration 
inhibition test has yielded further evidence. Nerup et al. (1973) 
performed leucocyte migration tests using foetal calf pancreatic ex­
tract as antigen. They concluded that in diabetes there is an organ- 
specific, species nonspecific, antipancreatic hypersensitivity." Nerup 
et al. (1973a) reported, in further experiments, that antipancreatic, 
cellular hypersensitivity was predominantly found in patients with 
juvenile diabetes of recent onset. MacCuish et al. (1974a) using 
human pancreatic antigen found a significant difference in migration 
inhibition between diabetics and control subjects.
Other experiments performed by Nerup et al. (1973a) showed that 
antipancreatic delayed hypers an j.’.Livity could be induced in rats by 
immunisation with a foetal calf pancreatic extract. Histological 
examination of the pancreas revealed mononuclear cell infiltration of
islets in these animals but not those immunised with insulin and 
Freund’s adjuvant. Wright et al. (1976) induced pancreatic lesions 
in rabbits and guinea pigs with various pancreatic antigens (whole 
bovine insulin and bovine insulin A component, and homogenates of 
the islets of Langerhans) but none of the animals developed defined 
signs of diabetes mellitus.
Other evidence for diabetes being an autoimmune disease comes 
from HLA associations. According to Bodmer and Bodmer (1974), dis­
eases showing the most significant association with histocompatibil­
ity antigens are autoimmune. It is possible that immune response 
genes linked to HLA genes may provide the basis for disease associa­
tions. Many investigators have shown an association of juvenile- 
onset insulin-dependent diabetes with certain HLA antigens, particu­
larly HLA B8 and B15 (Nerup et al., 1974; Cudworth and Woodrow, 1974, 
1975, 1976; Singal and Blajchman, 1973). Recent studies show a posi­
tive association with DW3, DRW3 and DRW4 antigens (Thomsen et al.,
1975; Nerup et al., 1976; De Moerloose et al., 1978).
The evidence in favor of an autoimmune basis for juvenile-onset 
diabetes mellitus is thus considerable. However, this does not pre­
clude the involvement of viruses and other environmental factors. It 
is possible that immune response genes linked to the HLA system con­
fer susceptibility to viruses which have an affinity for the pancre­
atic islet cells and this in turn leads to 3-cell damage which may then 
trigger an autoimmune response in susceptible individuals. The mechan­
isms whereby viruses may trigger autoimmune reactions will be discussed 
in Chapter II.
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Development of Autoimmunity. Irvine (1974) lists six distinct immune 
mechanisms, each of which, with the exception of type I, may be in­
volved in various endocrine disorders:
I. Anaphylactic (immediate hypersensitivity)
II, Immune complex (Arthus).
III. Cytotoxic antibody.
IV. T-cell mediated (delayed hypersensitivity)
V. Stimulating antibody
VI. Lymphoid (K) cell antibody mediated cytotoxicity.
From the foregoing discussion it is seen that both the T and B cells 
of the immune system have been implicated in the aetiology and patho­
genesis of diabetes mellitus. Recently, a third type of cell, the K 
cell, has been described which Irvine (1974) considers may have a 
major role in autoimmunity. These cells have receptors for activated 
Fc fragments of antibodies, i.e., complexed antibodies. If the antigen- 
antibody complex is on the surface of a target cell, then the K-cell 
will kill that cell. Also, immune complexes may be free in the circu­
lation and taken up by K cells reacting with the Fc fragment. Pro­
vided antibody is in excess, the K cell will acquire specificity to 
kill any cell which has the corresponding antigen on its surface and 
to which access is afforded. Antibody produced B cells may, in the 
presence of complement, have a direct cytotoxic effect on target cells 
but it may also form complexes, either on the surface of the target 
cell or free in the circulation. There is evidence that B, T, and K 
cells are operative in Hashimoto’s thyroiditis (Irvine, 1974). Calder 
et al. (1974) proposed three possible mechanisms of damage to the 
thyroid gland: the production of lymphokines, a cytotoxic mechanism
(sensitised T-cells), non-immune lymphoid cells and antibody and Fc
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receptor activation. The cytotoxic mechanism she describes involves 
the cellular and humoral components of the immune system in the patho­
genesis of autoimmune disease. It is possible that the same mechan­
isms apply in juvenile diabetes mellitus.
Investigations into the development of autoimmunity (Marx, 1975; 
Asherson and Zembata, 1976; Turk,. Polak, and Parker, 1976) have 
stressed the importance of the loss of self—tolerance and of suppres­
sor T cells. Burnet’s clonal selection theory (1959) states that con­
tact of lymphocytes and body constituents during embryonic life or in 
early postnatal development might destroy or permanently inactivate 
the complementary clones of lymphocytes which have the potential of 
reacting with an individual’s own antigens. He attributed autoimmun­
ity to the regeneration of ’’forbidden” clones of lymphocytes with 
specificities directed against self-antigens by a process of somatic 
mutation.
Another explanation of autoimmune damage is that it takes place 
against antigens hidden from the immune system. Sensitive tests, how­
ever, have shown the presence of certain proteins in the circulating 
blood (Allison, 1974). Tolerance has now been clarified by the demon­
stration of T and B lymphocytes and the helper effect of T cells in 
the formation of antibodies, and the induction of tolerance to pro­
teins that circulate in the blood in high concentrations. Low dose 
tolerance specifically inhibits the capacity of T cells to respond to 
antigen whilst high dose tolerance induces unresponsiveness in both T 
and B cells (Allison, 1974). On the basis of this, Allison suggests 
that many body proteins such as thyroglobulin and seme glycoproteins 
shed from cell membranes are present in the circulation in low doses, 
so T cells are unresponsive whilst B cells with receptors for these
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antigens can be stimulated to proliferate and secrete antibody. Such 
stimulation follows exposure to autoantigen in the presence of adju­
vant which causes T call stimulation. With antigens circulating in 
high doses, complementary B and T cells are inactivated and autoanti­
bodies would not be elicited by the above method. Tolerance maintained 
by specific unresponsiveness of helper T cells can be easily overcome, 
for example, by certain infections and Allison suggests that the 
"fail-safe mechanism" is the suppressor T-cell which gives a balance 
in preventing autoimmunity.
The importance of suppressor T-cells is verified by other work­
ers. Thus, Marx (1975) suggests that suppression is essential for the 
normal control of immune responses. Asherson and Zembata (1976) postu­
late that suppressor cells may play a role in the orderly sequence of 
different classes of immune response as: (i) some are damaging, (ii)
some interfere with the effectiveness of others, e.g., antibody and 
immune complexes interfere with cell-mediated responses, (iii) the 
type of immune response required depends upon the invading organism. 
Turk et al. (1976) consider the immune response to be the resultant of 
a balance between effector and suppressor elements, and that immuno­
logical tolerance can be thought of as the generation of a population 
of suppressor cells. If malfunction of this delicate balance occurs, 
then an excess of antibodies as in allergic reactions, or production 
of aberrant antibodies such as in autoimmune disorders, might prevail. 
Alternatively, there could be a lack of antibodies and consequent im­
munodeficiency (Marx, 1975). Many investigators consider that suppres­
sor T cells normally prevent the production of âutoantibodies and a 
deficiency may contribute to autoimmunity. Marx (1975) supports this 
view with the analogy of the progressive disease in NZB mice where
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there is a decrease of suppressor effects with age and the spontaneous 
development of a condition similar to systemic lupus erythmatosus in 
man. The cause of the loss of suppressor T cells is unknown, but 
viruses and genetic factors probably play a role (Marx, 1975). Williams 
and Messner (1975) suggest that a decline in T cells and T cell func­
tion, particularly suppressor T cells, in conjunction with an increase 
in B cells, might relate to the known increased incidence of autoanti­
bodies with old age.
Allison and Denman (1976) also postulate the involvement of 
viruses in the development of autoimmunity suggesting that viral anti­
gens and autoantigens could form common immunologic units which func­
tion in a manner analogous to the hapten-carrier system, and that by­
passing the requirement for T cells responsive against autoantigens, 
autoantibody formation might be elicited, e.g., by a viral infection.
Methods for Investigating Autoimmunity. The foregoing account out­
lines evidence for juvenile-onset diabetes being an autoimmune dis­
ease, the different types of immune reactions possibly involved, and 
the concepts as to the development of autoimmunity. Methods used in 
the investigation of autoimmune diseases may be considered under three 
main headings as proposed by Roitt and Doniach (1965):
( i) Evidence of abnormal immunological reactivity.
( ii) Association with known autoimmune disorders.
(iii) Study of experimental models.
The methods used to study abnormal immunological reactivity are: immuno­
fluorescence; passive haemagglutination, e.g., thyroglobulin antibody; 
agglutination of coated inert particles, e.g., latex particles coated 
with 5-globulin react with rheumatoid factors; complement fixation is 
well suited for estimations of antibodies to particulate tissue antigens
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e.g., subcellular fractions and crude extracts can be used; gel pre­
cipitation where formation of precipitating complexes between anti­
body and soluble antigen can be visualised in Ouchterhony plates, makes 
possible analysis of a complex mixture of antigens or antibodies; 
mixed agglutination where suitably coated red cells are used as indi­
cators for antigen present on living cells in tissue culture or on 
histological sections; cytotoxicity tests. Other methods not included 
by Roitt and Doniach are the leucocyte migration test and phyto- 
haemagglutinin transformation of lymphocytes which are both tests of 
cell-mediated (T-cell) function.
Scope of the Project. The intention in this investigation was, ini­
tially, to study an animal model in which diabetes was induced by a 
virus based on previous results presented by Gamble et al. (1969,
1973); Coleman, Gamble, and.Taylor (1973, 1974) and others who re­
ported the production of diabetes in mice after infection by various 
viruses (Craighead and McLane, 1968; From et al., 1968; Burch et al., 
1971; Craighead and Steinke, 1971; Wellman et al., 1972; Boucher and 
Notkins, 1973; Kanich, Craighead, and Kessler, 1973). Once a diabetic 
state had been induced it was intended to undertake further investiga­
tions to try to determine whether damage to the islet tissue was 
directly viral or involved an autoimmune component. The proposed 
plan of research was to study the effect of virus inoculation in neo- 
natally thymectomised mice which were later to be sublethally irradi- 
cated. Owing to the failure to induce a diabetic state after several 
experiments, the animal model idea was abandoned and all further work 
was the result of clinical investigation which was to have run in 
parallel with the animal studies. The clinical investigations were 
performed using lymphocytes from juvenile-onset diabetics and control
15
subjects and testing for leucocyte migration, phytohaemagglutinin trans­
formation, and cytotoxicity. In addition, patients and their families, 
when available, were HLA typed and their sera tested for the presence 
of autoantibodies.
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CHAPTER II.
Viruses and Diabetes Mellitus.
Introduction
Viral Infection and Autoimmunity. Before reviewing the evidence for 
the implication of viruses in the aetiology of diabetes mellitus, the 
mechanisms whereby a viral infection could precipitate an autoimmune 
attack will be Considered. Several authors have proposed theories to 
account for this process, including van Loghem (1965); Isacson (1967); 
Notkins, Mergenhagen and Howard (1970); and Allison (1972).
van Loghem (1965) associates the thymus gland with autoimmune 
conditions quoting the frequent finding of thymoma in patients with 
myasthenia gravis. He implicates viruses on the basis of the follow­
ing evidence:
(a) The presence of a pathogenic hepatotropic virus in mice 
thymectomised at birth. This is not present in non-thymectomised or 
sham-operated animals.
(b) The wasting syndrome (neonatally thymectomised mice waste 
after 1-3 months, probably as the result of being unable to combat 
infection) does not occur in germ-free thymectomised mice. It is pos­
sible that in normal mice a latent viral infection, otherwise suppres­
sed, becomes active when the thymus is removed.
(c) The wasting syndrome in mice can be prevented by the injec­
tion of syngeneic adult spleen cells. This indicates that the wasting
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syndrome and autoimmunity are not the direct result of thymectomy but 
could depend on viral infection.
(d) Normal mice thymectomised at birth and grafted with the 
thymus gland from NZB/BL mice suffering from autoimmune disease develop 
the same disease.
van Loghem (1965) considers, three mechanisms whereby viral in­
fections may lead to autoimmunity:
( i) Viral infection may be limited to the thymus, where regu­
lating function may be impaired and result in a lack of self-recognition 
by immunologically competent cells, with subsequent autoantibody forma­
tion.
( ii) Viral disease may start in the thymus and spread through­
out the immune system. Autoantibody might then be produced by viral 
interference with the DNA or RNA of clones of immunologically compe­
tent cells.
(iii) Viral infections may start in the thymus and spread to 
other organs evoking the transformation of target cells. Antibodies 
may then be formed against antigen coating the altered cells and these 
might cross-react with normal body constituents, van Loghem (1965) 
suggests that selective affinity of different viruses for organs and 
tissues could explain the large variety of autoimmune diseases.
It has been shown that viruses affect the immune system, in some 
cases, by depression of both primary and secondary responses, and in 
other cases by enhancing humoral immunity and by preventing immuno­
logical tolerance (Notkins et al., 1970). Notkins et al. suggest that 
the latter two effects might be important factors in the aetiology of 
autoimmune diseases, i.e., stimulation of the production of autoanti­
body. In addition. Levy and Notkins (1971) report that, in mice, under 
certain conditions viruses can act as immunologic adjuvant, preventing
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the development of tolerance and accelerating immunologic disease* 
They also state that in addition to the direct effect of viral repli­
cation on cellular function, the immune response may result in damage 
whereby antigens of the host are released or incorporated into the 
envelope of the maturing virion. These antigens might reach immuno­
logically competent cells and stimulate the production of antibody.
If these antigens come from hormone-producing cells, the immune re­
sponse might lead to endocrine dysfunction and might account for the 
autoantibodies found in certain endocrine disorders.
Autoimmune diseases could also result from the host's immune 
response to virus-induced antigens, i.e., if viral antigens are lo­
cated on the surface of hormone-producing cells, the interaction of 
sensitised lymphocytes or viral antibody plus complement, with these 
neoantigens might lead to cell destruction (Levy and Notkins, 1971). 
In support of this Wiktor, Kuwert, and Koprowski (1968) showed that 
tissue culture cells infected with rabies virus were lysed after ex­
posure to antirabies antibody and complement, and that the binding of 
viral antibody to the cell surface and cytolysis occurred before the 
release of the virions by budding.
Endocrine dysfunction could also result from the effects of cir­
culating virus-antibody complexes in the same way as the deposition 
of complexes in the kidney can result in glomerulonephritis. These 
circulating virus-antibody complexes have been shown to persist in 
mice chronically infected with anti-lactic dehydrogenase virus 
(Notkins et al., 1966). Levy and Notkins (1971) suggested that com­
plexes become lodged in the endocrine organs and cause lesions due to 
disseminated intravascular coagulation. McKay and Margaretten (1967) 
provided evidence that many viruses, including rubella and arbovirus,.
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can trigger the blood clotting mechanism. The proposed mechanisms are 
multiple:
1. Complexes may agglutinate platelets in vivo as they do in
vitro.
2. Viruses invade and damage endothelial cells leading to 
thrombus formation. Simultaneous, activation of the fibrinolytic sys­
tem may lead to dissolution and platelets may be swept into circula­
tion to produce coagulation at a distant site.
3. Some viruses cause haemolysis which promotes intravascular 
coagulation.
4. Antigen-antibody complexes in antigen excess are capable of 
triggering the clotting mechanism. It is conceivable that under cir­
cumstances of continual viral proliferation antibody might combine 
with the virus to form a procoagulant complex.
5. Antiplatelet antibody.
6 . Multiple mechanisms may be responsible.
Isacson (1967) proposed three mechanisms by which an autoimmune 
condition may arise as the result of a viral infection:
1. Antigenic modification of host cells.
2. Release of host antigens from concealed sites.
3. Antigenic similarity between host tissue and immunising 
agent. Thus, cross-reactive antigens may induce formation of antibody 
capable of reacting with antigen and host tissues.
He considered myxoviruses to be ideal inducers of autoimmunity 
by the first two and, possibly, the third mechanism. Neuramidase is 
present in the influenza and mump-NDV-parainfluenza viruses and is 
capable of antigenically modifying host cells. The other important 
feature of these viruses is their maturation at or near the cell
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surface. Influenza viruses are known to incorporate antigens de­
rived from cells in which they are grown; Lindenmann and Klein (1967) 
demonstrated in the mouse that cellular structures of low immuno- 
genecity become potent immunogens when integrated into the substance 
of viral particles.
Similarly, Allison et al. (1972) list five mechanisms whereby 
viruses could theoretically precipiate an autoimmune reaction. In 
addition to those proposed by Isaacson, there are the possibilities 
that viruses might derepress host cell antigens, e.g., embryonic 
antigens, or that they might affect the proliferation or responses of 
immunocompetent cells or their precursors.
Viral Associations With Diabetes Mellitus. Many viruses have been 
implicated in the aetiology of diabetes mellitus. These include 
mumps, hepatitus, rubella, Coxsackie and influenza viruses, adeno­
viruses, enteroviruses, and cytomegaloviruses (Maugh, 1975). How­
ever, Maugh (1975) states that any association can be dismissed as 
a coincidence because of the high incidence of both viral infections 
and diabetes mellitus. Brown (1956) was more convinced of the viral 
infective aetiology of some cases of juvenile diabetes and listed 
the evidence as follows:
1. A history of infection preceding diabetes, reported in 
15-98% of cases.
2. A seasonal variation in onset with fewer cases presenting 
in the summer.
3. The highest incidence of diabetes occurs in climates where 
streptococcal infections are greatest. Conversely, diabetes is rare 
in the tropics.
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4. Increased sedimentation rates and capillary fragility are 
found in diabetics which are indicative of infection.
The finding of families in which several members simultaneously 
develop diabetes is also suggestive of islet cell damage being ini­
tiated by an infectious agent. Thus, Nelson et al. (1977) reported 
one family in which three of five siblings with diabetic parents de­
veloped diabetes within a three-month period in the autumn.
Mumps has been the virus most frequently associated with the 
onset of diabetes. Maugh (1975) quotes a study in an isolated Swedish 
community where forty people contracted mumps and, of these, four de­
veloped diabetes the following year. This is a much higher incidence 
rate than expected. A more extensive study was carried out by Sultz, 
Hart, and Zielezny (1975) who collected data over a twenty-five year 
period. Their results were assessed, allowing a four-year period 
after the infection. They found that the incidence of diabetes 
paralleled that of mumps and mumps encephalitis. In addition, a 
sharp rise in the incidence of diabetes occurred in boys between 1950 
and 1960. Sultz et al. (1975) suggested that this could be due to 
the deliberate exposure of young boys to mumps to avoid adult orchi­
tis. They also interviewed 112 parents of diabetic children and 
found that in 50% of the cases mumps or exposure to mumps had pre­
ceded diabetes; furthermore, an additional 11% had received mumps 
vaccine prior to the onset of diabetes mellitus. The time lag period 
between infection and the onset of diabetes was 3.8 years. This 
agreed with results reported by Gundersen (1927) who found that the 
mortality rate from diabetes among young people reached a peak from 
two to four years after each mumps epidemic. McCrae (1963) found no 
time lag period and reported a single case of diabetes in a ten-
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month-old baby in whom the onset of diabetes was immediately preceded 
by mumps pancreatitis. He suggested that there might be a more sig­
nificant relationship between diabetes mellitus and those cases of 
mumps where the main site of infection is the pancreas. However, 
Gamble et al. (1969) in a study of antibody titre to a number of com­
mon viruses concluded that there- was no evidence for the development 
of diabetes after a mumps infection.
Rubella virus has often been associated with diabetes mellitus 
especially in the maturity-onset form. Forrest, Menser, and Burgess 
(1971) investigated fifty young adults who had sustained a congenital 
rubella infection and found only one with diabetes mellitus. In a 
survey four years later, when forty-four of these patients were still 
available for study, diabetes mellitus was diagnosed in five patients 
(11%) and latent diabetes in four (9%), giving a combined frequency 
of 20% which was much higher than normal. Dudgeon (1970) suggested 
that foetal damage in patients with congenital rubella might be due 
to the inhibition of cell growth, cytolytic activity, or interfer­
ence in the blood supply. Forrest et al. (1971) cite these mechan­
isms as of possible relevance to the development of diabetes. In 
contrast, in a later study quoted by Smithells et al. (1978) there 
were only two cases of diabetes in 482 children aged between 0-7 
years who had had confirmed or suspected congenital rubella. The 
same group quote an earlier survey of 83 patients aged 3-19 years 
retrospectively diagnosed as having had rubella, but none of whom had 
diabetes mellitus. However, Smithells et al. (1978) concluded that 
although the incidence of diabetes mellitus in individuals exposed 
to rubella in utero is low in the U.K., follow-up in the second or 
third decades of life may reveal a higher incidence of diabetes in 
these subjects.
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of the other viruses implicated in the cause of diabetes most 
attention has been focused upon a group of picomaviruses, the 
Coxsackie viruses, especially Coxsackie The Coxsackie viruses
are a group of small, common, RNA containing viruses which produce 
upper respiratory infections in man. Gamble et al. (1969) cited a 
previous study where two cases of Coxsackie B^ virus infection re­
sulted in necrotic lesions of the pancreas. They also quote unpub­
lished results where the Coxsackie B4 neutralising antibody titre 
rose from 1:512 to 1:1024 during the course of pancreatitis. Further 
studies of antibody titres to Coxsackie viruses B^_5 in diabetics of
recent onset, diabetics of more than two years' duration, and con-
aicti 'V iii'es
trol subjects revealed higher Coxsackie B4 virus^in the diabetics, 
and furthermore these titres were inversely proportional to the dur­
ation of diabetes (Gamble et al., 1969). Similar patterns were 
found for Coxsackie B^ and B4 viruses. Gamble, Taylor, and Gumming 
(1973) conducted a further survey of neutralising antibodies to 
Coxsackie B viruses, types 1-5, in 162 patients with insulin- 
dependent diabetes and 314 control subjects. This revealed a higher 
proportion of diabetics with neutralising antibody to Coxsackie B4 
virus. In addition, Capner et al. (1975) found a higher incidence of 
elevated neutralising antibody titres against Coxsackie B3 and B4 
viruses in a group of patients with acute pancreatitis compared to. 
control subjects.
However, these observations have been challenged. Hadden et 
al. (1972) studied 58 newly diagnosed diabetic patients in Northern 
Ireland. Thirty-four cf these subsequently required insulin, 15 re­
quired OHA, and 9 were controlled by diet alone. No predominance of 
any one Coxsackie virus was found, and there were no significant
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differences in the neutralising antibody titres among diabetics, hos­
pital control subjects, and laboratory control subjects. In addi­
tion, Nelson, Pyke, and Gamble (1975) in a study of identical twins, 
measured viral antibody titres to mumps, cytomegalovirus, rubella, 
Coxsackie Bi_5 virus, and Mycoplasma pneumoniae. They found that 
diabetic co-twins had no greater, incidence of antibodies to any of 
the viruses than the non-diabetic co-twins of discordant pairs.
Seasonal Incidence of Diabetes Mellitus. Further evidence of a viral 
cause of diabetes mellitus arises from the observation that diabetes 
is subject to seasonal variation. Gamble and Taylor (1969) suggested 
that such variations in the incidence of diseases may indicate that 
specific infectious agents are implicated, by correlation with their 
prevalence.
Many investigators have reported a seasonal variation in the 
incidence of diabetes mellitus since Adams in 1926, who showed a 
peak incidence in September and the lowest incidence in May and June. 
These results are in agreement with those of Brown (1956) who found 
the incidence to be lowest in the summer, Danowski (1957) who claimed 
there were slightly more new cases of diabetes in the winter months, 
and Christau et al. (1977) who found a reduction in incidence in May, 
June, and July. Gamble and Taylor (1969) reported pronounced varia­
tion in the incidence of insulin-dependent diabetes in patients 0-19 
years old, with a broad peak around October and the lowest incidence 
in June. This seasonal variation was much less noticeable in patients 
with insulin-independent diabetes. In addition to the seasonal vari­
ation, Gamble and Taylor (1969) showed a remarkable similarity in 
the incidence of insulin-dependent diabetes and Coxsackie B4 viral
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infections in patients between 0-19 years. In a further study.
Gamble et al. (1973) found a seasonal variation with peaks in Octo­
ber and January, but in this study the October peak was not mainly 
composed of patients who had antibody to Coxsackie virus. This 
is incompatible with the idea that diabetes is a direct sequel to 
Coxsackie virus infection since its peak incidence would be expected 
to occur in September or October. Gamble et al. (1973) suggested 
that a second or anamnestic response to another virus might be 
needed, and that this virus would have a similar seasonal incidence. 
An alternative explanation may be that delayed hypersensitivity re­
actions may play a part (Gamble and Taylor, 1977). The incidence of 
diabetes may reflect the incidence of an infection but be delayed by 
a short period. Thus, it is possible that diabetes is the result of 
an immunological event triggered in the autumn, the effects of which 
might become apparent over several months.
Virus-induced Diabetes in Animals. Several experimental studies have 
shown that animals may develop diabetes when exposed to certain viral 
infections. Thus, Maugh (1975q)quotes a report from Italy where cows 
developed pancreatic lesions and hyperglycaemia after foot and mouth 
disease, a condition which is caused by a picornavirus, the group 
that contains the Coxsackie viruses.
Another picornavirus, the encephalomyocarditis (EMC) virus has 
been shown to cause diabetes in mice. From et al. (1968) inoculated 
mice subcutaneously with the M variant of EMC virus and produced 
hyperglycaemia associated with insulin deficiency 8, 12, and 24 days 
after inoculation. Histologic examination of tissues from the in­
fected mice showed pathological changes in the islet cells but not
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the acinar cells of the pancreas. Craighead and McLane (1968) also 
used the M variant of EMC virus and reported hyperglycaemia with pan­
creatic lesions, and the recovery of large amounts of virus from the 
pancreas during the acute stage of infection when the islets of 
Langerhans exhibited focal necrosis and degranulation. In further 
experiments Craighead and Steinke (1971) injected male CD% mice sub­
cutaneously with the M variant of EMC virus and found that virus 
multiplication is associated with insulin release after which the 
level drops and hyperglycaemia ensues. They also discovered a sex 
and strain difference in susceptibility of mice to EMC virus, the 
incidence of diabetes being significantly lower in female mice and 
varying with different strains of inbred mice. Boucher and Notkins
(1973) also found sex and strain differences, inducing hyperglycaemia 
with the M variant of EMC virus in only DBA/2N and CD% mice from 
six strains of mice. This was explained on a genetic basis. Craig­
head and Steinke (1971) suggested that the predisposition to dia­
betes may possibly consist of an inability to replace defunct 3-cells 
and that damage may cause permanent diabetes, the severity of which 
reflects the extent of the lesion.
Wellman et al. (1972) inoculated CDi mice with the M variant 
of EMC virus and produced the expected hyperglycaemia but also ob­
served, after two days, disruption of the islets with 3-cell necro­
sis, degranulation, and mononuclear cell infiltration. They sug­
gested that the rapid effect noted with the virus is likely to be 
mediated by immune factors. Also using the M variant of EMC virus 
Kanich, Craighead, and Kessler (1973) produced a diabetlc-like syn­
drome in mice and in addition found lesions of the renal glomeruli.
Coxsackie viruses have been reported to replicate in the pan­
creas and induce hyperglycaemia in mice. This is of interest when
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considered in conjunction with the work of Gamble et al. (1969, 1973) 
who found high neutralising antibody titres to Coxsackie viruses in 
diabetics of recent onset. Burch et al. (1971) inoculated HaM/ICR 
mice intraperitoneally with 0.2 cc. Coxsackie B^ virus, TC 10^
and found pathologic changes in both endocrine and exocrine tissues 
of the pancreas. These changes ranged from focal and mild degenera­
tion to widespread necrosis and inflammation. They suggested an 
analogous situation in man where there is a high frequency of viral 
infections in childhood and early adulthood. If islet cell damage is 
extensive and irreversible, diabetes mellitus would be expected in 
the early part of life, whilst milder damage may not lead to diabetes 
or only later in life. Further experiments by Burch, Tsui, and 
Harb (1972) demonstrated EMC and Coxsackie B^ viral crystals in the 
3-cells and mild to severe pancreatic islet cell damage in HaM/ICR 
mice, and they claim that these results provide strong evidence for 
a viral aetiology in diabetes mellitus since direct viral invasion 
of the 3-cells followed by cell degeneration and necrosis, and later 
atrophic changes, can reduce the mass of functional 3-cells. This 
work was supported by Coleman et al. (1973) who inoculated male CD^ 
mice intraperitoneally with Coxsackie B4 virus. By day 12 some mice 
were obviously diabetic with a blood sugar level greater than 160 mg/ 
100 ml., although this was most noticeable between day 17-21 after 
inoculation. Microscopy revealed 3-cell degranulation and mono­
nuclear cell infiltation occurred around many damaged islets while 
acinar tissue degeneration was very limited. Further work by 
Coleman et al. (1974) using CD^ mice inoculated with unadapted 
Coxsackie B4 virus led them to believe that Coxsackie virus-induced 
diabetes in mice might serve as an appropriate model for diabetes in
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man, especially as Coxsackie B4 virus is a common human pathogen, 
Coleman et al. (1974) induced diabetes in 20-30% of CD^ mice 15-20 
days after infection and found that, as before, 3-cell degeneration 
was accompanied by mononuclear infiltation. It was suggested that 
the delay between inoculation and the onset of diabetic symptoms 
might indicate a mechanism involving some general response to viral 
infection rather than a direct attack on the islet cells by the 
virus.
From the foregoing review it is apparent that considerable 
differences of opinion exist as to which virus or viruses may play 
a part in the aetiology of diabetes mellitus. However, it is gener­
ally accepted that viruses may play some part in initiating some 
forms of diabetes.
Of the viruses proposed, Coxsackie B4 seems to be the most 
likely candidate because it has been shown to produce hyperglycaemia 
in mice; it is a common pathogen of man; and elevated antibody titres 
to type B4 have been found in newly diagnosed diabetics. In view 
of this, mice were inoculated with Coxsackie B4 virus to produce 
diabetes and to investigate the mechanism whereby diabetes was 
caused.
Materials and Methods
A series of experiments were performed using 8-9 week old, male 
CD^ mice. The experimental protocol in each case was as follows:
Experiment I. Forty mice were inoculated with 0-2 ml.
Coxsackie B4 virus, TC ID^g 10”'^”^ intraperitoneally (i.p.). Forty 
control mice were given an equivalent volume of saline i.p. Seven 
mice from each group were tested for glucose intolerance 4, 8, 11,
18, and 28 days after inoculation.
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Experiment II. This procedure was identical to that of the pre­
vious experiment, but the mice were tested for glucose intolerance 
3, 7, 14, and 37 days after inoculation with Coxsackie B4 virus.
Experiment III. Ten CDj mice were given an intravenous (i.v.) 
injection of streptozotocin (Upjohn, Ltd.) 60 mg/kg. in 0.2 ml. 
citrate buffer. Control mice were given an equivalent volume of buf­
fer. Blood sugar levels were measured 2, 4, 8, 14, and 30 days after 
injection.
Experiment IV. Five CD^ mice were given streptozotocin, 100 
mg/kg. i.v. Control mice were given an equivalent volume of buffer. 
The animals' blood sugar levels were measured 3 hours and 48 hours 
after injection.
Experiment V . Four groups of 15 mice were treated as fol­
lows:
(a) Controls. 0.2 ml. saline i.p.
(b) Cyclophosphamide 50 mg/kg. in 0.2 ml. saline i.p. on days 
0, 2, and 4.
(c) 0.2 ml. Coxsackie B4 virus, TC ID50 10“^“^ i.p. on day 7.
(d) Cyclophosphamide 50 mg/kg. i.p. on days 0, 2, and 4, fol­
lowed by 0.2 m. Coxsackie B4 virus i.p. on day 7.
Animals from each group were tested for glucose intolerance on 
day 14. The remaining virus treated animals were given a further 
injection of 0.2 ml. Coxsackie B4 virus i.p. on day 14 and tested 
for glucose intolerance on day 28.
The reagents required for glucose estimates are:
Protein diluent, 10 g Na2Wo^2H20, 10 g Na2HPG4 and 9gNaCl 
dissolved in 800 mis. distilled water. The pH was adjusted to 3.0 
with concentrated HCl; 1 gm. of phenol was added and the volume 
made up to 1 litre with distilled water.
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Colour reagent. 42 gm. Na2HP04 dissolved into 215 mis. of warm 
distilled water and 1.4 g. aminophenazone added.
Fermcozyme (952 DM).
Mice were fasted overnight, anaethetised with ether and 0.02 
mis. blood were taken from the tail into a blood pipette. Blood was 
transferred into 2.5 mis. protein diluent and mixed thoroughly. The 
mixture was then centrifuged at 400 g for 5 mins. and 2 ml. of the 
supernatant removed and added to 0.5 ml. of a colour reagent and 
fermcozyme mixture which was prepared immediately before use, 2 ml. 
fermcozyme being used for every 15 ml. colour reagent. The solution 
was left at room temperature for 15 minutes and read in a spectro­
photometer at 500 nm. against a blank containing no glucose. Stand­
ard solutions of glucose were prepared containing 50, 100, 200, 300, 
and 400 mg/100 ml. From the readings obtained a calibration curve 
was drawn and the glucose in the unknown blood samples determined.
Where glucose tolerance tests were performed, the animals were 
given an i.p. injection of 50 mg. glucose and blood sugar levels 
determined at time 0 and at 30, 90, and 120 minutes after injection. 
In addition to glucose tolerance tests, routine histology of the 
pancreas was performed in experiments I, II, and V.
Results
In experiment I mice were injected i.p. with Coxsackie B^ virus 
while control mice were injected with an equivalent volume of saline. 
The results of glucose tolerance tests performed at various times 
after the inoculation of virus are shown in Figure 2.1. The shaded 
areas on the graphs represent the control values, mean + standard 
deviation.
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4 days after injection of virus
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Fig. 2.1 Glucose tolerance tests on control mice end mice 
injected with 0.2ml per 25g body weight of 
Coxsackie 84 virus, TCID so 4.5.
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The results from day 4 showed considerable variation, with the 
blood sugar levels of the control mice being approximately double 
those of the virus treated mice at all stages of the test.
The blood sugar levels of mice tested on day 8 again showed 
variation. Three virus-treated animals revealed high blood sugar 
levels 30 minutes after the administration of dextrose. However, two 
mice from this group had comparatively low blood sugar levels.
The results obtained on days 11, 18, and 28 show greater repro­
ducibility but do not give any indication of glucose intolerance in 
the virus-treated animals compared with the controls. When the mean 
blood sugar levels of the test and control mice were compared, there 
was no difference.
In the second experiment mice were treated in the same way to 
that described for experiment I. However, the mice were tested for 
glucose intolerance 3, 7, 14, and 37 days after inoculation with 
virus or injection of saline. Some signs of glucose intolerance were 
observed in two virus-treated animals on day 7 and one on day 14. 
However, there was no difference in the mean blood sugar levels of 
either group at the various stages of the glucose tolerance test (Fig­
ure 2.2).
Experiment III. Streptozotocin was administered to mice in 
order to induce diabetes through a direct pancreatic effect and 
thereby have a control diabetic animal against which virus-induced 
diabetic animals could be compared. Blood sugar levels of streptozo­
tocin- treated and control mice were measured 2, 4, 8, 14, and 30 days 
after injection. The results are shown in Table 2.1. The blood 
sugar levels varied with time after injection, but the only appreci­
able difference between the test and control levels was on day 8 . 
Thereafter there was very little difference.
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Fig 2.2 Glucose tolerance tests on control mice and mice 
injected with 0.2ml per 25g body weight of 
Coxsackie 84 virus, TCI D so 4.5.
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Table 2.1. Mean blood sugar levels of mice treated with 60 mg/kg
streptozotocin i.v. at various intervals after injection 
compared to control mice
Time After 
Injection (Days)
Mean Blood Sugar Level mg/100 ml.
Control Test
2 173 (not fasted) 143 (not fasted)
4 77.4 73.8
8 78 129
14 80.6 99.3
30 128 141
As no permanent elevation of blood sugar level resulted from 
60 mg/kg streptozotocin, a further experiment was performed where mice 
were injected i.v. with 100 mg/kg streptozotocin and the blood sugar 
levels measured 3 hours and 48 hours later. Four of five mice in­
jected with streptozotocin revealed markedly elevated blood sugar 
levels two days later, while the control values remained the same 
(Table 2.2).
Table 2.2. Blood sugar levels of 5 mice treated with
streptozotocin (100 mg/kg i.v.) and 5 saline- 
treated controls, measured 3 and 48 hours 
after injection
Blood Sugar Level mg/100 ml.
3 hrs. 48 hrs.
Control Test Control Test
70 97 79 390
102 125 89 370
102 98 77 94
76 88 82 325
82 72 118 201
The blood sugar levels measured 3 hours after injection of strep­
tozotocin revealed no difference from control values.
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Experiment V. All animals were tested for glucose intolerance 
14 days after the beginning of treatment. No abnormalities in blood 
sugar levels were noted in any of the three groups treated with virus 
and cyclosphosmide, virus only, and cyclophosphamide only when com­
pared to control values. (Figure 2.3.1). As there was no evidence 
of glucose intolerance in the virus treated animals, the experiment 
was modified. Those animals receiving virus plus cyclophosphamide or 
virus alone were given another i.p. injection of Coxsackie virus 
on day 14 of the treatment and tested for glucose intolerance 28 days 
after the beginning of the treatment. The results are shown in Fig­
ure 2.3.2. No glucose intolerance was observed compared to the con­
trols in either of the virus-treated mice.
The histological examinations of mouse pancreas performed on 
animals in experiments I, II, and V revealed no changes in the struc­
ture of the acinar or islet tissue.
Discussion
In the experiments described, Coxsackie B^ virus failed to in­
duce diabetes in CD^ mice. The absence of any abnormal glucose tol­
erance curves was apparent. Coleman et al, (1974) reported diabetes 
in 20-30% of CD^ mice 15-20 days after inoculation with Coxsackie 
B^ virus, in association with 8-cell degranulation and mononuclear 
infiltration. In the experiments carried out here using the same 
strain of mice, treated at the same age with Coxsackie B^ virus', no 
diabetes was observed and histology showed the islet cells to be 
normal with no mononuclear infiltration. These results are in agree­
ment with those reported by Ross, Hayashi, and Notkins (1974) and 
Craighead (1975) who were unable to reproduce Coleman's results. Ross
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Fig. 2.3.1 Glucùse tolerance tests on mice injected with 
0.2ml per 25g body weight Coxsackie 84 virus, 
TCIDso, estimated 14 days after cyclophosphamide 
injection and 7 days after viral injection with:
(1) Virus only
(2) Virus and cyclophosphamide
(3) Cyclophosphamide only.
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Fig. 2.3.2 Glucose tolerance tests on control mice and mice 
injected with 0.2ml per 25g body weight 
Coxsackie S4 virus, TCI D 50, estimated 28 days 
after cyclophosphamide injection and 14 days 
after a further inoculation of Coxsackie virus 
with;
(1) Double inoculation of virus
(2) Double inoculation of virus and pre­
treatment with cyclophosphamide.
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et al. (1974) inoculated various strains of mice, including DBA/2 and 
CDj strains, with Coxsackie B viruses types 1-5, and the M variant of 
encephalomyocarditis virus. They found that the Coxsackie B viruses 
produced pancreatic acinar damage with little or no effect on the is­
lets and no resulting hyperglycaemia. Passage of Coxsackie B4 virus 
via pancreatic homogenates, in order to enhance any diabetogenic poten­
tial proved ineffective in the induction of hyperglycaemia. Mice in­
fected with EMC virus, however, became hyperglycaemic with damage to 
the B-cells but not to the acinar cells of the pancreas. Maugh (1975a) 
reported that Notkins had examined fifteen strains of Coxsackie 
viruses and found no 3-cell damage or abnormal glucose tolerance even 
when using the same strain of virus and the same type of mice as 
Coleman et al. (1973).
In the present study no evidence of diabetes was found in re­
sponse to Coxsackie B^ virus after cyclophosphamide pretreatment. If 
the virus were acting directly on the islet cells, then this pre­
treatment would be expected to enhance the action and result in more 
severe hyperglycaemia. Alternatively, if the virus triggers an im­
mune response which is effective in damaging the islet cells, then 
pretreatment with cyclophosphamide would be expected to result in 
less damage to the islets. However, from these experiments it is not 
possible to postulate either mechanism of action.
Double inoculation of mice with Coxsackie B^ virus also pro­
duced no diabetes which further supports the claim that Coxsackie B4 
virus does not normally cause hyperglycaemia by pancreatic islet cell 
damage in CD^ mice (Notkins, 1977). Whether the virus is acting 
directly or triggering an immune response, double inoculation within 
14 days would be expected in the first instance to have an additive 
effect and in the latter case, a magnified effect corresponding to 
a secondary immune response.
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There are several possible reasons for not being able to repro­
duce the work of Coleman et al. (1973, 1974). Maugh (1975fe)suggests 
that diet may play a part as CD^ have been known to spontaneously 
develop diabetes mellitus when fed on a high fat diet. It is also 
possible that the virus became attenuated, although this is unlikely 
in view of the fact that Notkins- used the same strain as Coleman et 
al. (1973). The other possibility is genetic variation in the mice 
used as CD^ mice are not an inbred strain. Notkins (1977) suggested 
that conflicting reports might be due to the fact that, in general, 
mouse 3-cells are resistant to infection by Coxsackie B viruses and 
that if viral damage occurs, it is usually insufficient to cause per­
sistent hyperglycaemia.
Evidence from studies in animals (Coleman et al. 1973, 1974) 
and in man (Gamble et al., 1969) suggested that Coxsackie B^ virus 
might be a causative agent in diabetes mellitus and that CD^ mice in­
fected with this virus might provide a good animal model. However, 
the experiments described here and those reported by Ross et al.
(1974) and Craighead (1975) show that CD^ mice infected with Coxsackie 
B^ virus cannot be used as a reliable animal model. In fact, con­
siderable evidence has been published against the involvement of 
Coxsackie B^ virus in diabetes mellitus. Since Gamble et al. (1969) 
work showing high neutralising antibody titres to Coxsackie B^ virus, 
many workers have found no connection between diabetes and this 
virus. Wales and Hambling (1973) followed-up 24 patients who were 
diagnosed for Coxsackie B2 or B^ virus infection in the period 1968- 
1972 and found that no patients or members of their families had de­
veloped diabetes. They suggested that any connection of Coxsackie 
B^ virus as an aetiological agent must be in the nature of an abnormal
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or delayed response to such infection. Hierholzer and Farris (1974) 
reported that of 94 children who were infected with Coxsackie B3 and 
B^ virus in 1968, none showed any signs of diabetes four years later. 
They concluded that their results showed no association between juve- 
nile-onset diabetes and Coxsackie viruses. Nevertheless, it is pos­
sible that diabetes may become apparent in genetically predisposed 
individuals after a multitude of random infectious, chemical, or 
immunologic insults to the pancreas. In a similar study, Dippe et 
al. (1975) found no evidence of an increase in diabetes mellitus dur­
ing a five-year period after a Coxsackie B^ virus epidemic in the 
Pribiloff islands, even though diabetes was as common in the islanders 
as in the Caucasian population. They found no cases of diabetes in 
anyone under 20 years of age even though 77% of this group had anti­
bodies to Coxsackie B^ virus. In addition, there is a lack of evi­
dence that newly diagnosed diabetics transmit to others an agent that 
induces the disease within a short period (Mann et al., 1978).
Notkins (1977) reviewed the subject of a viral aetiology for 
diabetes mellitus and suggested that since the incidence of both dia­
betes and acute viral infections is high in children, any other rela­
tionship might be coincidental.
The results obtained from this study and those obtained by 
other workers militate against the involvement of Coxsackie B^ virus 
as a causative agent of diabetes mellitus in man. The discrepancies 
from animal studies support this view. However, it is possible that 
Coxsackie B^ virus, in susceptible individuals, may be one of many 
environmental factors that initiate diabetes mellitus.
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CHAPTER III.
Leucocyte Migration Inhibition Test.
Introduction
The leucocyte migration inhibition test has been used for a 
number of years as an in vitro correlate of delayed or cell-mediated 
hypersensitivity (Bendixen and Soborg, 1969; Dumonde et al., 1969; 
Brostoff, 1970; Roitt, 1971). According to Brostoff (1970) thymus- 
dependent lymphocytes, on contact with antigen, transform to blast 
cells and release soluble factors, including migration inhibition 
factors. Lomnitzer, Rabson, and Koornhof (1975) suggested that the 
leucocyte migration test is dependent upon the production of a 
lymphokine which acts specifically on polymorphonuclear leucocytes. 
This factor can be demonstrated using a capillary tube migration 
technique first proposed by Bendixen and Soborg (1969).
Leucocyte migration inhibition has been shown in a number of 
autoimmune diseases including pernicious anaemia (Brostoff, 1970; 
Goldstone et al., 1973), primary biliary cirrhosis (Brostoff, 1970), 
ulcerative colitis (Bendixen and Soborg, 1969), Hashimoto thyroidi­
tis (Brostoff, 1970; Calder et al., 1972), and in juvenile-onset 
diabetes (Nerup et al., 1971, 1973; Richens et al., 1973, 1974); 
MacCuish et al., 1974a).
In addition to producing inhibition by the use of specific 
antigens in this test, e.g., thyroglobulin in Hashimoto thyroiditis
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and intrinsic factor in pernicious anaemia, many workers have reported 
migration inhibition using liver mitochondrial extracts (Brostoff, 
1970; Goldstone et al., 1973; Calder et al., 1972; Richens et al., 
1973, 1974). Leucocyte migration inhibition is considered to be a 
generalised marker of autoimmune disease (Brostoff, 1970; Calder et 
al., 1972; MacCuish et al., 1974} since it has been variously reported 
to be organ non-specific (Calder et al., 1972) and species non­
specific but organ specific (Richens et al., 1973).
The leucocyte migration inhibition test has been used in 
studying juvenile-onset diabetes. Hence, Nerup et al. (1971) found 
typical delayed hypersensitivity in four of seven diabetics where 
six had low migration indices. They used, as antigen, subcellular 
fractions of porcine islet tissue obtained by ligation of the pan­
creatic duct, a procedure which results in atrophy of the acinar tis­
sue but leaves the islet cells intact. Nerup et al. (1971) results 
suggested an organ specific, species non-specific, antipancreatic 
hypersensitivity. In experiments using rats in which antipancreatic 
delayed hypersensitivity was induced using foetal calf pancreas in 
complete Freund's adjuvant, Nerup et al. (1973a) found that spleen 
cell migration was inhibited in the majority of treated animals and 
that islet cell changes were detectable when migration inhibition 
factor was maximal. In further experiments, Nerup et al. (1973) per­
formed migration inhibition tests on ninety-seven diabetics and 
forty-five control subjects using a foetal calf pancreatic extract 
as antigen, and found a significant reduction in the mean migration 
index in the diabetic patient gro^p. Within this group of diabetic 
subjects, it was found that the newly diagnosed patients showed sig­
nificantly greater inhibition than the other groups.
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MacCuish et al. (1974a) also carried out leucocyte migration 
tests on one hundred and one diabetic patients and fifty control sub­
jects using human pancreatic extract as antigen. They found inhibi­
tion in seventeen of thirty-one young diabetics aged under 42 years, 
compared to four of twenty-seven age-matched control subjects.
When MacCuish et al. (1974a) used rat liver mitochondria as 
antigen in the leucocyte migration test, they found no difference in 
inhibition among young diabetics, control subjects, and older dia­
betics. Richens et al. (1973), however, using rat liver mitochondria 
and human liver mitochondria as antigens, found marked differences in 
inhibition of leucocytes from insulin-dependent diabetics, insulin- 
independent diabetics, and control subjects. In further experiments 
using inner and outer mitochondrial membranes, Richens et al. (1974) 
found inner membranes inhibited migration more than outer membranes 
in a group of eighteen insulin-dependent diabetics. These results 
suggest that diabetes may be related to other conditions considered 
to be of autoimmune origin, and Richens et al. (1974) proposed that 
hypersensitivity to mitochondria might reflect altered T-cell reac­
tivity.
The following experiments were carried out on blood from dia­
betic patients, when available, with a view to verifying previous 
results and correlating this immune reaction with other immunological 
and genetical aspects of diabetes such as phytohaemagglutinin trans­
formation, islet cell antibodies, and histocompatibility antigens.
Materials and Methods
The method used here was based upon that of Bendixen and Soborg 
(1969). This test is based upon the supposition that lymphocytes
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from sensitised donors, on contact with specific antigen, produce 
soluble factors which affect leucocyte migration, whilst in the ab­
sence of antigen or in the presence of lymphocytes from a non­
sensitised donor, migration remains unaffected.
For the test 20 ml. of venous blood were taken and heparinised 
(20 U/ml.). The blood was allowed to sediment at 37® C for 30 min­
utes when the leucocyte rich plasma was removed and centrifuged at 
400 g for 5 minutes. The cell pellet was washed three times in 
Eagles medium M.E.M. (Wellcome Laboratories, Beckenham) supplemented 
with 10% foetal calf serum, resuspended and the cells counted. The 
concentration was adjusted to 5 x 10^ cells/ml, and then 25 pi. 
capillary tubes were filled with this suspension. These were sealed 
at one end and centifuged at 400 g for 5 minutes. The tubes were 
then cut just below the cell/medium interface and the pellet posi­
tioned in a Sterilin leucocyte migration chamber with silicone grease, 
The chambers were then filled with culture medium (Eagles M.E.M. and 
foetal calf serum) supplemented with penicillin and streptomycin 
(100 U/ml.) and one of several antigens at a concentration of 100 
pg/ml. The antigens used were Coxsackie B^ virus, rat liver 
mitochondria, and pancreatic cell fractions. Control chambers were 
filled medium alone.
Cultures were performed in quadruplicate for each given antigen 
and the chambers sealed with cover slips using silicone grease. They 
were incubated for 24 hours at 37® C on a flat surface. The pattern 
of migration was then projected onto paper, the outline drawn, and 
the area measured by planimetry. The effect of antigen on migration 
was then expressed as a migration index calculated as:
mean migration with antigen 
mean migration without antigen"
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A figure of less than 0.80 was taken to indicate significant inhibi­
tion and a figure greater than 1.20 significant stimulation.
Preparation of Antigens and Protein Estimation. Coxsackie virus 
was obtained from the Public Health Laboratory, Royal United Hos­
pital, Bath.
Pancreatic tissue was obtained from a cadaver at the time of 
renal transplant, usually within half an hour of death, and rat 
liver from a freshly killed rat. The tissue was diced into small 
pieces and diluted ten times with 0.25 M ice cold sucrose solution. 
The mixture was then homogenised with a Potter-Elvehjem homogeniser 
and filtered through muslin to remove the fibrous tissue. All pro­
cedures were carried out at 0° C. In the preparation of the pan­
creatic homogenate two enzyme inhibitors were added to the sucrose 
according to the method of Lendrum and Walker (1975). The inhibitors 
were epsilon aminocaproic acid (0.6% w/v) and trasylol (100 U/ml.). 
The tissue homogenates were centrifuged differentially to obtain 
various subcellular fractions according to methods quoted by Murray, 
Suss, and Pitot (1967) and Lendrum and Walker (1975):
Preparation
Homogenate 
Supernatant A 
Supernatant B 
Supernatant C
Time Resultant
G Force (mins.) Fraction
600 g 10 Nuclei + debris
1000 g 10 Nuclei
6000 g 20 Mitochondria
105000 g 60 Microsomes
Supernatant
A
B
C
The pellets were resuspended in the original volume of 0.25 M 
sucrose, aliquoted into 0.5 cc. volumes and frozen at -20° C until 
required. The final suspension was used once and any remaining in 
the tube discarded.
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Protein estimation was determined by the method of Lowry et al. 
(1951). The following reagents were used:
Combined Reagent
A. 5% CUSO4
B. 10% Na/K tartrate
C. 2% Na2C0g in 0 IN NaOH
D. Folin-Ciocalteaux Reagent diluted 1:1 with water
E. Standard protein solution - bovine serum albumin 60 pg/ml.
The combined reagent was prepared by adding 1 ml. of B to 1 ml. of A 
and diluting to 10 ml, with distilled water, and then taking 1 ml. 
of the resulting solution and diluting to 50 ml. with solution C.
For the calibration curve the tubes were prepared as fol­
lows :
Tube HqO (ml.) Protein (60 yg/ml.) Combined Reagent F+C Reagent
1 1.00 0.00 ml. 5 ml. 0.5 ml.
2 0.75 0.25 ml. 5 ml. 0.5 ml.
3 0.50 0.50 ml. 5 ml. 0.5 ml.
4 0.25 0.75 ml. 5 ml. 0.5 ml.
5 0.00 1.00 ml. 5 ml. 0.5 ml.
The test solution was usually diluted 1:50 and 1:100 in order to ob­
tain a reading within the range of the calibration curve. One ml. of 
the diluted test solutions was added to further tubes instead of 1 ml, 
of standard protein solution. All samples were duplicated and read 
after 30 minutes in a spectrophotometer at 700 mp against a water 
blank.
Results
Figure 3.1 shows the results of migration inhibition tests 
against antigens Coxsackie B^ virus, rat liver mitochondria, and 
human pancreatic fractions in insulin-dependent diabetics, insulin- 
independent diabetics and control subjects. The mean migration
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indices all lie within the 0.80-1.20 range in each of the groups 
tested, but migrations against Coxsackie virus, mitochondria, and 
pancreatic fractions in the insulin -dependent group show migration 
values outside this range, 19%, 42%, and 44% of those subjects tested, 
respectively. For the insulin-independent group these values are 9%, 
9%, and 30%, respectively, and for the control group 7%, 5%, and 5%, 
respectively.
Stimulation was shown in 8.5%, 2%, and 6% of insulin-dependent 
diabetics against Coxsackie B4 virus, mitochondria, and pancreatic 
fractions, respectively, compared with 45%, 0%, and 10% in insulin- 
independent diabetics, and 7%, 5%, and 10% in the control group.
Table 3.1 shows the mean migration indices and standard devia­
tions from insulin-dependent diabetics who were tested at different 
times after diagnosis. Inhibition of migration as indicated by the 
mean migration index was found against mitochondria and pancreas in 
diabetics tested one year or later after diagnosis. In the group 
tested 0-6 months after diagnosis 21% showed inhibition of migration 
against Coxsackie B4 virus, 33% against mitochondria, and 35% against 
pancreatic fractions. In the patients tested one year or more after 
diagnosis 63% showed inhibition against mitochondria and pancreatic 
fractions, whereas none showed inhibition against Coxsackie B4 virus 
although the number tested here was very small.
Figure 3,2 shows the variation in migration indices when 
tested at various times after diagnosis. Over relatively short 
periods the migration index varies considerably, in one case by 0.48 
3V3r a period of 4 ninths, the patient showing inhibition with an 
index of 0.67, which rises to 1.15 and can almost be called stimula­
tion. In the case of the control only three sequential results were
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obtained from which very little can be deduced, although the values 
were virtually identical.
Discussion
Altered in vitro reactivity of leucocytes probably reflects 
cellular hypersensitivity against components of rat liver mitochon­
dria and pancreatic fractions in the case of insulin-dependent dia­
betics, and cellular hypersensitivity against a pancreatic component 
in the case of insulin-independent diabetics. It is interesting 
that this hypersensitivity is more pronounced in the insulin- 
dependent diabetics and may possibly indicate a greater autoimmune 
component involved in the aetiology of this form of diabetes.
The results support the theory that diabetes has an autoimmune 
component in its aetiology by linking this disease with other con­
ditions thought to have an autoimmune basis. Cellular hypersensi­
tivity to liver mitochondria has also been shown in several other 
conditions such as Addison*s disease (Nerup and Bendixen, 1969), and 
primary biliary cirrhosis (Brostoff, 1970) where inhibition is con­
sidered to be organ-specific. Calder et al. (1972) found inhibition 
by mitochondria in Hashimoto thyroiditis to be organ 
non-specific, and Goldstone et al. (1973) results of inhibition by 
mitochondria in pernicious anaemia suggest that this is also non­
specific. Richens et al. (1973) in migration inhibition studies in 
diabetics found that the reaction was apparently specific to liver 
mitochondria but species non-specific. It is generally accepted 
that inhibition by mitochondria in these conditions is non-specific 
and a general manifestation of autoimmune disease (Brostoff, 1970; 
Calder et al., 1972; Richens et al., 1973; MacCuish et al., 1974a). 
The results presented here support those found by Richens et al.
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(1973, 1974) but not those of MacCuish et al, (1974) who found no in­
hibition by mitochondria in diabetics. Irvine et al. (1977) were 
also unable to confirm Richens et al. (1973, 1974) findings but sug­
gested the difference in results may be due to the preparation of 
the liver mitochondrial fraction.
Stimulation of migration has been reported to be associated with 
weak sensitisation to an antigen whilst inhibition is considered to 
be the result of strong sensitisation (Soborg, 1967).
Stimulation of migration occurred in both the diabetic and con­
trol groups to a small degree. The only exception was the insulin- 
independent group against Coxsackie B4 virus where stimulation was 
pronounced. Forty-five percent of this group showed stimulation, 
although the number tested was only eleven. However, if this stimu­
lation is considered as weak sensitisation, then combining the re­
sults with those showing Inhibition gives a total of 55% sensitised 
to Coxsackie B^ virus compared to 28% of the insulin-dependent dia­
betics and 13% of the control subjects. However, there was only one 
subject whose leucocytes showed inhibition when cultured with 
Coxsackie B^ virus. This mild sensitisation found in the insulin- 
independent group might possibly reflect a mild infection with lit­
tle resulting damage to the pancreas compared to the insulin-dependent 
diabetics where a more severe infection leads to greater damage and 
consequent dependence on insulin.
The results obtained using pancreatic fractions as antigen 
showed sensitisation in both the insulin-dependent and insulin- 
independent group, although this more pronounced in the former 
group. The results are in agreement with those of Nerup et al.
(1974), MacCuish et al. (1974), and Irvine et al. (1977) who found
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antipancreatic cellular hypersensitivity in juvenile-onset diabetics. 
However, when the insulin-dependent diabetic group was subdivided 
into untreated juvenile diabetics or those treated for less than a 
year and those treated for a year or more, Nerup et al. (1974) found 
a significant difference in migration inhibition. When the group 
studied here was subdivided, the, mean migration indices were below 
the 0.80 mark in diabetics tested a year or more after diagnosis but 
above 0.80 in the group tested within six months of diagnosis.
Nerup et al. (1974) state that their results agree with previous 
findings and the lymphocytic infiltration found in the pancreases of 
recent onset juvenile diabetics.
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CHAPTER IV.
Phytohaemagglutinin (PHA)-induced Transformation 
of Lymphocytes
Introduction
Roitt et al. (1969) state that on contact with antigen, T- 
lymphocytes transform into large blast cells and divide both in 
vivo and in tissue culture. This proliferation of sensitised cells 
on contact with specific antigen has frequently been used as an in 
vitro test for cell-mediated hypersensitivity (Roitt, 1974).
Roitt et al. (1969) proposed that these T-lymphoblasts sub­
serve several functions:
1. They may divide further to give a larger population of 
primed antigen-sensitive cells which provide immunological memory;
2. They may serve as "killer" cells which are cytotoxic 
for graft cells;
3. They may release a number of soluble factors;
4. They may cooperate by stimulating antigen-sensitive B-
lymphocytes.
The induction of mitosis in cultured small lymphocytes and 
their transformation to blast cells can also be effected by non- 
immunological stimuli such as the non-specific mitogens PHA and 
Concanavalin A (Con A) (Roitt et al., 1969).
PHA is commonly utilised for its mitogenic activity in vitro 
for the estimation of thymus-dependent (T) lymphocyte reactivity
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(Koch and Nielsen, 1975). PHA probably stimulates T-cells non- 
specifically (Roitt, 1974, p. 153), but it may also stimulate B- 
cells by an indirect mechanism. Jacobson and Blomgren (1975), 
working with mouse lymphoid preparations exposed to phytomitogens, 
showed the release of soluble factors from T-cells which are mito­
genic for both T- and B-cells. In a further study Blomgren (1976) 
showed that T- and B-cells are both able to produce mitogenic 
factors. This is in agreement with the finding that the classical 
T-cell product, migration inhibition factor is released by T- and 
B-cells (Bryceson,1974 ). In addition. Potter and Moore (1977) re­
port that highly purified T-cell populations respond poorly to PHA 
and that responsiveness can be enhanced by the addition of a small 
number of cells from a monocyte-rich population. Blomgren (1976) 
also notes that the DNA synthetic responses of human T-cells, cul­
tured with phytomitogens, may be strongly enhanced by non-T-cells. 
However, it is generally accepted that PHA transformation is pri­
marily a response of the T-cell population. Roitt et al. (1969) states 
that the transformed cells contain no intracellular immunoglobulin 
suggesting that they come from the T-cell population and that the 
known correlation.of transformation with delayed hypersensitivity 
accords with this view. Roitt (1974, p. 152) states that PHA 
transformation has been frequently used as an in vitro test for cell- 
mediated hypersensitivity and several studies have shown reasonable 
correlation with in vivo results. Thus, Greaves and Janossy (1972) 
carried out experiments in mice and with reference to humans, the 
evidence was compatible with the view that PHA stimulates onk^T-cells, 
whilst pokeweed mitogen stimulates both T- and B-cells. Kreeftenberg.
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Leerling, and Loggen (1975) found that PHA predominantly activates 
T-cells, although 10-20% of the blast cells are derived from B-cells.
PHA is a macromolecule with a molecular weight > 30,000 (Greaves 
and Janossy, 1972), the chemical composition of which is unknown 
(Koch and Nielsen, 1975). It reacts non-specifically with the 
lymphocyte cell surface triggering the same series of events as 
does antigen combining to a specific surface receptor (Roitt, 1974, 
p. 153), With PHA the majority of T-cells are transformed, whereas 
with antigen stimulation only a small number of cells are sensitive 
(Roitt, 1969, 1974).
The first report of PHA responsiveness in diabetes came from 
Brody and Merlie (1970). These workers compared five insulin- 
dependent and one insulin-independent diabetics with seven patients 
with chronic lymphocytic leukaemia. Both of these diseases show a 
lack of resistance to infection, and Brody and Merlie (1970) found 
an overall significant depression in PHA responsiveness in both dia­
betics and leukaemias when compared to control subjects. They sug­
gested that the lymphocyte may be metabolically abnormal in diabetes 
and that this could ultimately lead to defective DNA synthesis, 
failure of antigenic recognition, and clinically deficient immunity. 
Ragab, Hazlett, and Cowan (1972) determined the responsiveness of 
cells from the peripheral blood of diabetics (seventeen taking in­
sulin, three chlorpropamide, and three treated by diet alone) to 
PHA and found no difference from the control subjects. However, in 
this case the diabetics were in good clinical control with only four 
patients with blood s^'gar in eircess of 250 mg/100 ml. In Brody and 
Merlie (1970) study four of the six diabetics had blood sugar above 
300 mg/100 ml., although these were the highest values observed during
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treatment. MacCuish et al. (1974b) measured PHA responsiveness in 
forty well controlled, insulin-dependent diabetics, fourteen poorly 
controlled, insulin-dependent diabetics, and forty control subjects 
and found a significantly decreased response in the poorly con­
trolled diabetics compared to both other groups. MacCuish et al. 
(1974b) also reported that there.were no differences in circulating 
subpopulations of lymphocytes in any of the groups described, a 
finding supported by Hann, Kaye, and Falkner (1976). MacCuish et al, 
(1974b) concluded that the depression in PHA responsiveness reported 
by Brody and Merlie (1970) reflects a metabolic disturbance rather 
than any inherent immunologic abnormality. Further support for the 
results of MacCuish et al. comes from Mahmoud et al. (1976) who 
found cell-mediated responses were reduced in streptozotocin-induced 
diabetic mice and concluded that this is due to alteration in the 
metabolism and function of the lymphocyte in diabetes.
This study was undertaken to investigate cell-mediated immun­
ity in insulin-dependent diabetics with a view to correlating this 
with other immunological features and HLA antigens.
Materials and Methods
Twenty cc. of venous blood were taken and mixed with preserva­
tive-free heparin at 20 U/ml. (Weddel Laboratories). The lympho­
cytes were separated on a Ficoll-Triosil column, specific gravity 
1.073, and washed in phosphate buffered saline and then a further 
three times in culture medium consisting of :
TC 199 Tfith Earles Salts buffered with 20 mM Hepes (Wellcome 
Labs)
Penicillin and Streptomycin, 150 U/ml.
Foetal Calf Serum, 10% by volume of medium
2 mM L-glutamine
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Phosphate buffered saline was prepared in the following way;
NaJQ 32 g.
KCl 0.80 g.
Na2HP042H20 5.10 g.
KH2P0^ 0.80 g.
in a volume of four litres of distilled water which gives a final 
solution pH 7.35 + 0.05. The lymphocytes were counted and adjusted 
to 0.75 X 10^ cells/ml. in culture medium.
Two cc. of culture medium and lymphocytes were pipetted in 
round bottomed plastic tubes (112 mm. x 13 mm.) and 010 cc. of PHA 
of various dilutions were added. A dose-response curve was carried 
out in each case using the equivalent of 0, 0.01, 0.02, and 0.04 cc. 
of the original PHA in the final volume of medium. Each determina­
tion was carried out in triplicate. The cells were cultured in 
stoppered tubes for 72 hours at 37® C. A radioactive pube., con­
sisting of 0.1 cc. of tritiated thymidine, 2 y Ci. (Radiochemical 
Centre, Amersham) was then added to each tube. Cultures were termi­
nated four hours later by cooling to 0® C. The cells were harvested 
onto glass fibre filter paper (Whatman AF/C). Material remaining in 
the tube was washed onto the pad with 40 cc. ice-cold phosphate buf­
fered saline, and the protein precipitated with 20 cc. of ice-cold 
5% trichloroacetic acid. The pads were finally washed with 20 cc. 
methanol and dried in an oven at 120® C. for four hours. They were 
then placed in vials containing 10 cc. scintillation fluid )0.4%
PPG, 0.005% POPOP in toluene) and counted in a scintillation counter, 
the results being given in c.p.m. or d.p.m.
All procedures prior to culturing of the cells were carried out 
in sterile conditions under an ultra-violet lamp. Glassware was 
sterilised by wrapping in tin foil and heating at 200® C. for three 
hours. Phosphate buffered saline was autoclaved and the medium
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sterilised by passage through a 0.22 y filter, and Ficoll-Triosil by 
passage through a 0.45 yfilter.
Ten insulin-dependent diabetics, mean age 30 years 1 month, 
were compared with 10 control subjects, mean age 28 years, who were 
age and sex-matched where possible.
Results
In order to determine the optimal quantities of PHA to be used 
in routine transformation experiments, general dose-response curves 
were performed initially. The results of these are seen in Table 
4.1, and it was decided to use 0, 0.01, 0.02, and 0.04 cc. PHA in 
future experiments.
Table 4.1. Mean DPM obtained on adding ^H-thymidine to 
cultures of 1.5 x 10^ lymphocytes from con­
trol subjects in the presence of varying quan­
tities of PHA.
DPM (mean)
PHA (ml.) Expt. 1 Expt. 2 Expt. 3
0 1542 718 4678
0.01 59018 36286
0.02 46971
0.025 43929
0.03 55050
0.04 25189
0.05 30977
0.10 6543 48386
Figure 4.1 shows the results of experiments using lymphocytes 
from 10 control subjects and 10 insulin-dependent diabetics. The re­
sults shown here are the mean DPM values for each PHA volume. The 
diabetic group shows a slight depression in PHA response when compared 
to the control group.
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Fig. 4.1. 1.5 X 10 lymphocytes from each of 10 insulin-dependent diabetic patients
(mean age 30 years 1 month) and 10 control subjects (mean age 28 years) 
were incubated in the presence of varying quantities of PHA. Transforma­
tion was estimated by measuring the uptake of ^H-thymidine. The results 
are expressed as DPM + SEM for both groups of subjects.
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Figures 4.2 and 4.3 show the results of individual experiments 
when the mean DPM values from triplicate cultures were plotted 
against PHA volume for one control subject and one diabetic patient. 
In both cases the diabetic lymphocyte response to PHA was greatly 
depressed. However, in other experiments there was little differ­
ence between the responsiveness of lymphocytes from the control sub­
jects and the diabetic patients; in some cases the diabetic lympho­
cyte response was greater than that of the control subject.
There was considerable variation in responses to PHA when in­
dividual subjects were compared. This is shown by the large stand­
ard errors of the mean obtained when the results were aggregated.
The standard error of the mean of the control responses was less than 
that of the diabetic responses.
Discussion
The results presented here of the mean PHA transformation from 
10 diabetic patients show a small depression in response. This is 
in agreement with both Brody and Merlie (1970) and MacCuish et al. 
(1974b). However, both these groups of investigators found signifi­
cant differences only between the control subjects and poorly con­
trolled diabetic patients. MacCuish et al.(1974b) suggest that this 
reflects a metabolic disturbance rather than an abnormality in the 
lymphocyte, as suggested by Brody and Merlie (1970).
Of the ten diabetic patients tested here only two showed any 
significant depression in the lymphocyte response to PHA. There 
were both recent diabetics tested within four months of diagnosis, 
and of late onset for juvenile-type diabetes. However, at the time 
of testing both had satisfactory blood sugar levels. Consequently,
Fig. 4.2. Transformation of lymphocytes from one insulin-dependent 
diabetic and one control subject incubated with varying 
quantities of PHA. Results are expressed as mean DPM + 
standard deviation.
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Fig. 4.3. Transformation of lymphocytes from one insulin-dependent dia­
betic and one control subject incubated with varying quantities 
of PHA. Results are expressed as mean DPM + standard deviation.
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these results tend to support the suggestion of Brody and Merlie 
(1970). Their ages were 35 and 45 years, respectively. The control 
subjects against whom these two patients were compared were 24 and 
26 years, respectively. According to Girard et al. (1977) respon­
siveness to PHA shows a progressive decrease from the age of 40.
This may be an explanation of the depression found in one of the two 
experiments presented here. Another factor to be considered is the 
reported decrease in the absolute number of T-lymphocytes with age 
(Girard et al., 1977). In the experiments reported here lymphocytes 
were separated on a Ficoll-Triosil column. Hence no distinction was 
made between T- and B-cells. The reduced DPM*s obtained with the 
older subjects may be a direct reflection of T-cell number. In addi­
tion, results presented by Cattaneo, Saibene, and Pozza (1976) show 
a decrease in the absolute number and percentage of E-rosette- 
forming cells (T-cells) in the peripheral blood of juvenile-onset 
diabetics in comparison with maturity-onset diabetics and control 
subjects. On this basis PHA transformation of diabetic lymphocytes, 
obtained by separation of whole blood on a Ficoll-Triosil column, 
would be expected to be lower than in control subjects, as there 
would be an overall decrease in the number of T-lymphocytes obtained 
from diabetic patients. However, both MacCuish et al. (1974b) and 
Hann et al. (1976) report normal numbers of circulating subpopula­
tions of lymphocytes in insulin-dependent diabetics.
Diurnal rhythms may also cause fluctuations in PHA responsive­
ness. Thus, Eskola et al. (1976), using whole blood, report low 
responses from blood taken at C8.00 hours and high response from 
blood taken at 20.00 hours.
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It has also been shown that high circulating levels of oestro­
genic and progestagenic steriods in women cause a significant de­
pression of PHA response (Barnes et al,, 1974). Therefore, those 
women who are pregnant or taking oral contraceptives would be ex­
pected to show a decreased PHA response.
In order to eliminate as many factors as possible, the diabetic 
and control populations should be carefully age- and sex-matched, 
venopuncture should be performed at a constant time, and the E- 
rosetting procedure should be adopted to ensure response from a known 
number of T-cells.
Pooled data from the ten diabetic patients and ten control sub­
jects showed great variation between individual experiments. This 
is reflected by the large standard error of the mean. At a PHA vol­
ume of 0.01 cc., the control values varied from 12000 to 51000 DPM, 
while the test values varied from 8000 to 77000. This causes the 
large standard error in a group so small as ten. The only way to 
compare diabetic and control lymphocyte responsiveness to PHA is on 
an individual basis, taking into account the factors described 
above.
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CHAPTER V.
Autoantibodies in Diabetes Mellitus.
Introduction
An increased incidence of autoantibodies in diabetics compared 
to control subjects has been reported by several workers (Irvine et al., 
1970; Nerup and Binder, 1973; Bottazzo et al., 1974; MacCuish et al., 
1974). Nerup and Binder (1973) reported an association between dia­
betes and other autoimmune disorders and found that antibodies to thy­
roid cytoplasm and gastric parietal cell cytoplasm occurred with sig­
nificantly increased frequency in diabetics. These results confirmed 
those of Irvine et al. (1970) who found an increased frequency of 
thyroid and gastric parietal cell antibodies in both insulin- 
dependent and insulin-independent diabetics regardless of the dura­
tion of diabetes. Lendrum et al. (1975) found twenty of one hundred 
and five diabetic patients possessed either thyroid or gastric parie­
tal cell antibody or both, whereas thyroid antibody was found in only 
one control subject and gastric parietal antibody in two. Bottazzo 
et al. (1974) state that the prevalence of thyroid and gastric anti­
bodies is three times higher in juvenile diabetics than in age and 
sex matched controls. They point out, however, that in the older 
population diabetes and thyroiditis are common conditions and are 
present in subclinical form in up to 20% of this group. When this 
is considered, the association between diseases is less impressive.
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However, when autoimmune adrenalitis and insulin-dependent diabetes 
are considered, the association is far more striking, Bottazzo et al.
(1974) report the incidence of overt diabetes in idiopathic Addison's 
disease as being 10% compared to 1% in the general population, and 
that adrenal antibodies are found thirty times more often in insulin- 
dependent diabetics than in control subjects.
The simultaneous occurrence of two or more antibodies to thy­
roid, adrenal cortex, or gastric parietal cell cytoplasm has been re­
ported in patients with diabetes but not in control subjects (Nerup 
and Binder, 1973). In addition to the three organ specific autoanti­
bodies described above, MacCuish et al. (1974) claim that antibodies 
to intrinsic factor are increased four times in diabetics compared 
with controls.
The increased incidence of these organ specific antibodies in 
diabetes supports autoimmune involvement. Further evidence comes 
from an association with other autoimmune disorders such as perni­
cious anaemia, thyrotoxicosis, Hashimoto thyroiditis, idiopathic hypo­
parathyroidism and myasthenia gravis (MacCuish et al., 1974). The con­
cept of autoimmunity in diabetes mellitus was further strengthened by 
the discovery of islet cell antibodies (ICA) in patients with polyen- 
docrine disorders (Bottazzo et al., 1974; MacCuish et al., 1974). 
Bottazzo et al. (1974) reported the presence of IgG, complement fixing 
islet cell antibodies in thirteen of seventy-one sera; ten of these 
thirteen positive patents were diabetic. MacCuish et al. (1974) 
found islet cell antibodies in five of one hundred and five sera; the 
positive cases were juvenile-onset. Insulin-dependent diabetics with 
co-existent Addison's disease and adrenal antibodies. Nerup and 
Binder (1973) failed to demonstrate antibodies to the islets of
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Langerhans in patients with diabetes and associated autoimmune dis­
orders. Bottazzo et al. (1977) proposed that these antibodies were 
not seen by several observers because of technical factors including 
low light transmission, the comparatively weak fluorescence produced 
by these antibodies, and the possible interference of blood group 
substances normally secreted by the acini so that group A or B 
organs give fluorescence with many sera (Lendrum and Walker, 1975).
Since the first report of islet cell antibodies in patients 
with polyendocrine disorders, many investigators have detected them 
with increasing frequency. Lendrum et al. (1975) found fifty-one of 
one hundred and five juvenile diabetics under the age of eighteen 
and less than one year's duration possessed ICAs. Among the ICA 
positive patients, six had thyroid antibody, two gastric parietal 
cell antibody, and two possessed both. They suggested that ICAs were 
present for a limited period only after the onset of diabetes and 
that their presence in adults occurred only when accompanied by other 
autoimmune disorders. This was based on the finding that sera from 
patients obtained a year or more after diagnosis were negative. This 
view has since been confirmed by Lendrum et al. (1976) who found that 
in almost every case of newly diagnosed juvenile diabetes weak ICAs 
are present in the sera and that this incidence falls to 50% within 
seven weeks and less than 20% within a year. Studies in identical 
twins also revealed a decline in positive ICA patients with increas­
ing time after diagnosis (Lendrum et al., 1976). Irvine et al.
(1977) found ICAs in 65% of newly diagnosed insulin-dependent dia- 
bet-»c.s, but within one to twelve months the prevalence was 55% end 
40% with one to two years, 20% within two to five years, 10% within 
five to ten years, and 5% within ten to twenty years. Bottazzo et al.
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(1977) tested ten ICA positive diabetics twelve to fourteen months 
later and found much lower titres with five being completely nega­
tive.
In newly diagnosed patients ICAs are found in 60-85% of juve­
nile diabetics (Lendrum et al., 1975). Irvine et al. (1977) report 
that 70% of juvenile-onset diabetics possess ICAs at the time of 
diagnosis compared to 0.5% of the general population. Lendrum et al. 
(1976) found 59% of diabetics of less than one year duration had 
ICAs. They had previously reported (Lendrum et al., 1975) only one 
out of seventy-two control subjects were positive.
MacLaren and Huang (1975) performed immunofluorescent tests 
using cultured human insulinoma cells. These are considered to be 
closely related to the islet 8-cell. They found 87% of insulin- 
dependent diabetics were ICA positive. Sorenson, Shank, and Elde
(1975), using an immunoperoxidase method tested sera for the presence 
of islet binding immunoglobulins and found that juvenile diabetics 
have an elevated titre over age matched control subjects. Lendrum 
et al. (1975) estimation of 60-85% of newly diagnosed diabetics are 
ICA positive was further confirmed by Bottazzo et al. (1978) who 
found 74% of diabetics studied within three months of diagnosis had 
ICA. When patients were studied three or more years after diagnosis, 
less than 20% were ICA positive.
The incidence and titre of ICA is higher in diabetics with 
other autoimmune disorders and the ICA persists for many years 
(Bottazzo et al., 1977). Irvine et al. (1977) found the incidence 
of ICA in insulin-treated diabetics with other autoimmune diseases 
was 38% and without other autoimmune diseases was 22%. Non-diabetics 
with autoimmune disease had a higher incidence of ICAs, 5.6%
70
compared to 0.5% of control subjects. Bottazzo et al. (1978) found 
that persistence of ICA was associated with a high prevalence of 
thyrogastric autoimmunity,
ICAs are often found in patients who have not developed dia­
betes. Bottazzo et al. (1977) report a case of a woman with poly­
endocrine disease who had a high, titre of ICA and who developed dia­
betes two years later. Lendrum et al. (1976) show that ICAs may be 
present in people with normal glucose tolerance and may precede 
clinical diabetes by as much as three and one half years. Irvine,
Gray, and McCallum (1976) proposed that ICAs may be a marker for 
asymptomatic and latent diabetes after carrying out glucose toler­
ance tests in thirty-six subjects who had ICAs but not diabetes. Most 
ICAs detected so far are IgG and fix complement (Bottazzo et al.,
1974). MacLaren et al. (1975) found that the antibodies to cultured 
human insulinoma cells were of the IgG and IgM class. ICAs are 
organ specific and appear to react with all the cells of the islets, 
probably directed against the cytoplasmic organelles concerned in the 
synthesis or transport of hormones (Bottazzo et al., 1977). Other 
autoantibodies, reacting to pancreatic glucagon and somatostatin 
cells independently of ICAs have also been found (Bottazzo and Lendrum, 
1976) mainly in insulin-dependent diabetics but also in insulin- 
independent diabetics and control subjects. A specific glucagon 
antibody has also been reported in a diabetic patient given no insu­
lin (Baba et al., 1976).
In this study ICAS and other autoantibodies were studied by 
immunofluorc3cent techniques in insulin-dependent c.nd insulin- 
independent diabetics. It was intended to correlate these with the 
incidence of other autoimmune phenomena under study.
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Materials and Methods
The tissues used as substrates in these studies came from vari­
ous sources. Human pancreas was obtained at death from blood group 0 
renal transplant donors; thyroid tissue was obtained from thyroidec­
tomy operations. Other tissues used were obtained fresh from mice 
and stomach, liver, and kidney were mounted together to form a com­
posite block. Once removed the tissues were cut into approximately
0.4 cm. cubes with a sharp scalpel and snap frozen in liquid nitro­
gen. The tissues were then mounted on liquid nitrogen precooled 
chucks, using a drop of saline. They were then stored in liquid 
nitrogen until required.
Cryostat sections were cut at -22® C at a thickness of 6 y, 
whereupon they were placed on standard microscope slides and allowed 
to dry under an electric fan for at least half an hour. Slides pre­
pared in this way can be stored at-70® C and used for several weeks.
The immunofluorescent technique used here was based on the 
double layer method for antibody detection. Sera were obtained
from insulin-dependent and insulin-independent diabetics and from con­
trol subjects and stored at -70® C until required.
The cryostat sections were covered with sera preheated to 
37® C to avoid misleading antinuclear antibody (ANA) reactions. They 
were left for 30 minutes at 37® C and then washed for 20 minutes in 
phosphate buffered saline (PBS) on a rotatable. The PBS was care­
fully wiped off the slide leaving the sections well moistened, and 
one drop of conjugate (anti-human IgG fluorescein conjugate for the 
detection of ICAs and a polyclonal immunoglobulin fluorescein conju­
gate for the detection of other autoantibodies) was placed on each
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section. The slides were left in a moist box for a further 30 min­
utes and the sections then washed for 40 minutes in PBS. The sec­
tions were then mounted in glycerol buffer which was prepared as 
follows:
Glycine 14.0 gm.
Sodium hydroxide (solid) 0.7 gm.
Sodium chloride . 17.0 gm.
Sodium Azide 1.0 gm.
made up to 1 litre with distilled water. For mounting 1 part buffer 
to 2 parts glycerol were used which gave a buffer of pH 8.6 at 
which fluorescence is maximal (1969).
The conjugates used in these tests were obtained from Burroughs 
Wellcome Ltd. Anti IgG was used at a dilution of 1:8 for detection 
of ICAs (Lendrum and Walker, 1976) and polyclonal immunoglobulin at 
a dilution of 1:80 for the detection of other autoantibodies. Neat 
sera was used on pancreatic sections whilst a 1:10 dilution was used 
on thyroid and composite block sections.
Fluorescence was detected using a Reichert microscope and view­
ing the sections with an ultraviolet light source.
Blocking and specificity tests were performed using sera posi­
tive for ICAs. In the specificity test serum was added to the pan­
creatic section for 30 minutes, washed for 20 minutes, and fluorescein 
labelled sheep antirabbit IgG (1:8) was added instead of sheep anti­
human IgG, i.e., specific conjugate was replaced by a conjugate 
against an unrelated antigen.
In the blocking test serum was added to the pancreatic section 
as before and then unlabelled specific antibody (antihuman IgG, 1:8) 
was added. After washing, specific labelled antibody (sheep anti­
human IgG, 1:8 d:l) was added. The principle of this control is
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based upon the combination of the unlabelled antisera (blocking anti­
body) with the corresponding human immunoglobulin, thus blocking the 
antigen sites which are normally available for reaction with fluore­
scein labelled antibody. This leads to diminution or inhibition of 
fluorescence in preparations incubated with the blocking reagent, of 
the same immunological specificity as that of the fluorescent conju­
gate, prior to conjugate application.
As a control the double layer immunofluorescence technique, as 
described, was performed.
Absorption studies were initiated in order to determine the 
antigen against which ICA is reacting. These studies were performed 
on ICA positive sera with the following antigens: pancreatic homoge-
nate, mitochondria, and microsomes and Coxsackie B4 virus, prepared 
as previously described. Coxsackie B4 virus was included as there is 
evidence of its involvement in initiating diabetes and reports of 
high neutralising antibody titres in newly diagnosed juvenile diabe­
tics (reviewed in Chapter II).
The method used here was based on that of Lendrum and Walker 
(1976). Sera were incubated with equal volumes of either the antigen 
or PBS for 24 hours at 4° C. The mixtures were then centrifuged at 
100,000 G for 1 hour, the supernatant removed and tested for ICAs as 
above.
Results
Sixty juvenile-onset insulin-dependent diabetics with a mean 
age of 24 years 6 months and a mean duration of diabetes of 5 years 
1 month were tested for the presence of ICAs. Figure 5.1 shows typical 
islet cell staining with positive ICA serum. Of the 60 diabetic
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Fig. 5.1. Typical pancreatic islet cell staining with the serum of 
a newly diagnosed juvenile-onset diabetic, using human 
pancreas in the indirect immunofluorescent technique.
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patients tested 33% were positive for ICA. However, the incidence of 
ICAs was found to decline with the duration of disease, from 62% in 
those patients studied within 3 months of diagnosis to zero in those 
patients of more than 5 years duration (Table 5.1).
Table 5.1. Incidence of ICAs in 60 juvenile-onset insulin- 
dependent diabetics at various times after 
diagnosis.
Time after 
diagnosis
ICA
-Hve
ICA
-ve
0 - 3 months 13/21 62% 8/21 38%
3 - 6 months — —
6 - 1 2  months 2/2 100% 0/2 0%
0 - 1 year 15/23 65% 8/23 35%
1 - 5 years 5/19 26% 14/19 74%
> 5 years 0/18 0% 18/18 100%
Thirty-three maturity-onset insulin-independent diabetics were also 
tested. They had a mean age of 63 years 3 months and a mean duration 
of diabetes of 3 years 5 months. None were ICA positive.
None of the 10 control subjects, mean age 28 years 6 months, 
were ICA positive.
In an additional group of 14 first degree relatives of insulin- 
dependent diabetics, 3 (21%) were ICA positive. The results are shown 
in Table 5.2.
The presence of other autoantibodies such as thyroid, gastric 
parietal cell, antinuclear, reticulin, smooth muscle, and mitochondrial 
were compared in the four groups (Table 5.2). One of 8 controls 
(12.5%), who were tested on all tissues, revealed the presence of at 
least one autoantibody compared to 40/59 (68%) of juvenile-onset insu­
lin-dependent diabetics and 13/21 (62%) of mature-onset insulin- 
independent diabetics.
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Table 5.2. Incidence of autoantibodies in 60 insulin-dependent dia­
betics, 14 first degree relatives, 33 insulin-independent 
diabetics and 10 control subjects.
Tissue
Autoanti­
body
Insulin-
Dependent
Diabetics
1st
Degree
Relatives
Insulin-
Independent
Diabetics
Control 
Subjects
Islet Cell 
Antibody
Thyroid
G.P.C.
Others
20/60 (33%) 
11/58 (19%) 
12/57 (21%) 
17/58 (29%)
3/14 (21%) 
2/14 (14%) 
0/14 ( 0%) 
6/14 (43%)
0/33 ( 0%) 
3/29 (10%) 
5/21 (24%) 
9/21 (43%)
0/10 ( 0%) 
0/8 ( 0%) 
0/8 ( 0%) 
1/8 (12 1/2%)
Antibodies to thyroid cytoplasm were found in 19% of insulin- 
dependent diabetics compared to 10% of insulin-independent diabetics 
and 0% of control subjects.
Gastric parietal cell antibody was found in 21% and 24% of pa­
tients with insulin-dependent diabetics and insulin-independent dia­
betics, respectively, and none of the controls.
Other autoantibodies (antinuclear, mitochondrial, reticulin 
and smooth muscle) were found in 29% of insulin-dependent diabetics, 
43% of insulin-independent diabetics, and 12 1/2% of control sub­
jects.
When the first degree relatives were considered for thyroid, 
gastric parietal cell and Other autoantibodies, the figures were 14%, 
0%, and 43%, respectively.
Fifteen of 59 or 25% of insulin-dependent diabetics studied 
possessed at least two autoantibodies compared to 14% of the insulin- 
independent diabetics and none of the controls. Of the first degree 
relatives, 36% possessed at least two autoantibodies.
Results of the blocking and specificity tests performed with 
ICA positive sera from 4 insulin-dependent diabetics are shown in 
Table 5.3. Where sheep antirabbit IgG was used instead of sheep
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antihuman IgG, no islet cell fluorescence was observed with any of the 
sera. Similar results were obtained when unlabelled specific anti­
body was used.
Table 5.3. Fluorescence (+) or lack of fluorescence (-) observed from 
4 ICA positive diabetic sera on pancreatic sections when 
nonspecific antibody, unlabelled specific antibody, and 
labelled specific antibody were used.
Diabetics
Serum + 
Antihuman IgG
Serum + 
Antirabbit IgG 
(Specificity)
Serum + Unlabelled 
Antihuman IgG 
(Blocking)
1 + - -
2 + - -
3 + - -
4 + - -
Absorption studies with positive ICA sera from 4 insulin- 
dependent diabetics using pancreatic antigens and Coxsackie B4 virus 
revealed the results shown in Table 5.4. In 3/4 cases there was in­
creased intensity of fluorescence with the pancreatic homogenate, 
whilst 3/4 sera absorbed with Coxsackie B4 virus showed less intense 
fluorescence than control sera incubated with PBS. Sera absorbed 
with pancreatic mitochondria and microsomes produced mixed results 
with some of the sera showing increased fluorescence and others show­
ing no fluorescence.
Table 5.4. Intensity of fluorescence (0 to +++) obtained from 4 ICA
positive sera when incubated with various antigens and PBS
Patients
Serum PBS
Pancreatic
Homogenate
Pancreatic
Mitochondria
Pancreatic
Microsomes
Cox B4 
Virus
1 44- 4-44- 44- 0 4-
2 44- 444- 44-f 0 4-4-
3 44- 444- 4-H- 44- 4-
4 44- 44- 0 -H4- 4-
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Discussion
The results presented here are in agreement with those of Irvine 
et al. (1970), Nerup et al. (1973), Bottazzo et al. (1974), MacCuish 
et al. (1974), and Lendrum et al. (1975) with respect to the increased 
incidence of thyroid and gastric parietal cell antibody in insulin- 
dependent diabetics. The incidence of thyroid antibody was 19% and 
that of gastric parietal cell antibody was 21% compared with the fig­
ures of 20% and 16%, respectively, reported by Nerup and Binder
(1973) and the 20% for either thyroid or gastric parietal cell anti­
body, or both, reported by Lendrum et al. (1975). An increased in­
cidence in thyroid and gastric parietal cell antibody was also found 
in insulin-independent diabetics compared with control subjects and 
this is in agreement with the results of Irvine et al. (1970). How­
ever, the insulin-independent group used in the present study had a 
mean age of 63 years 3 months compared to the control group mean age 
of 28 years 6 months. It is well known that there is an increase in 
autoantibody production with age and, consequently, it would be ex­
pected to find an increased incidence of autoantibodies in this group, 
where the age of onset of diabetes is much greater than that of the 
insulin-dependent group. This appears to be confirmed by the finding 
that 43% of the insulin-independent mature-onset diabetics possessed 
antibody other than those to islet cells, thyroid, or gastric parie­
tal cells compared with 29% of insulin-dependent diabetics and 
12 1/2% of control subjects.
The simultaneous occurrence of two or more autoantibodies in 
25% of insulin-dependent diabetics is also in agreement with results 
published by Nerup and Binder (1973) and emphasises an autoimmune 
component in this type of diabetes. In accordance with this is the
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finding that 36% of first degree relatives of insulin-dependent dia­
betics possess two or more autoantibodies and may point to a genetic 
predisposition to autoimmunity in these families.
Confirmation that islet cell antibodies are common in newly 
diagnosed juvenile-onset insulin-dependent diabetics is supplied 
here. Thus, 65% of patients tested within one year of diagnosis 
showed the presence of ICAs; this is comparable to the figures of 
Lendrum et al. (1975) of 60-85%. That these antibodies tend to dis­
appear is also apparent as only 26% of diabetics tested 1-5 years 
after diagnosis and none of those tested over 5 years after diagno­
sis possess ICAs. Persistence of ICA in diabetes is usually asso­
ciated with other autoimmune disorders (Bottazzo et al., 1977). In 
this study 2/5 juvenile diabetics with ICA present one year or more 
after diagnosis revealed the presence of thyroid or gastric parietal 
cell antibody whereas only 1/14 who were negative for ICA in this 
group possessed thyroid antibody. However, there was no clinical 
manifestation of other autoimmune endocrine disorders. One patient 
whose serum was tested at the time of diagnosis still showed the 
presence of ICA over one year later. In addition, he possessed anti­
bodies to both thyroid and gastric parietal cell cytoplasm.
Islet cell antibody appears to be almost exclusive to newly 
diagnosed juvenile-onset diabetes and was not seen in any of the 
mature-onset diabetics suggesting that ICAs are of significance in 
the aetiology of type I diabetes. When ICAs are found in patients 
other than juvenile-onset diabetics, it is usually in association 
with polyendocrine disorders (Bottazzo et al., 1974). Bottazzo et 
al. (1974) suggested that it may be of value in predicting diabetes 
in these patients as the ICA is often present before the onset of 
diabetes.
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The role of ICA in the pathogenesis of diabetes mellitus is un­
known. Bottazzo et al. (1977) think that they are useful as markers 
which separate two types of insulin-dependent diabetes, lA and IB.
The lA type includes uncomplicated juvenile, insulin-dependent dia­
betes where the disorder could be due to viral infection. The fact 
that ICAs are transient is compatible with this view as transient 
autoimmune reactions are known to occur in viral infections. Type IB 
diabetes includes the polyendocrine cases with onset at any age. 
Bottazzo et al. (1977) subdivide these as follows:
Type lA
Aetiology Viral
Overall frequency of DM 10%
Insulin-dependent Yes
Sex M = F
Age < 30
Associated autoimmune dis­
orders None
Incidence of other autoanti­
bodies Low
Frequency of ICA
First appearance of 
ICA
At onset 85% 
After 1 year 20% 
Tend to disappear
Time of viral in­
fection
Type__IB
Related to organ- 
specific autoimmunity
< 1%
Yes
F > M
Any age
Adrenalitis, gastri­
tis, thyroiditis
High
Not known 
38%
Remain stable for years
Years before onset of 
diabetes mellitus
However, Irvine et al. (1976) regard the presence of ICAs in patients 
with polyendocrine autoimmune disorders as a marker for asymptomatic 
prediabetes.
In this study no distinction has been made between type lA and 
type IB, the diabetics being divided into insulin-dependent (the 
majority of whom were diagnosed before the age of 30) and insulin- 
independent or mature onset, so it is not possible to confirm this
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subdivision of insulin-dependent diabetes according to the frequency 
and association of autoantibodies. In addition, the numbers in the 
Bath area were low and there are insufficient data for any meaning­
ful analyses.
MacLaren et al. (1975) carried out Immunofluorescent tests using 
insulinoma cells instead of pancreatic sections. They found positive 
fluorescence in 34 of 39 diabetic patients but were uncertain whether 
this marker of au to immunity was primary (involved in the pathogenesis) 
or secondary (as a result of diabetes). They suggested that 8-cell 
damage, possibly by a virus, might initiate an immune response by re­
leasing sequestered antigens. Alternatively, immune 8-cell damage 
might result from either complement-fixing antibody cytotoxicity or 
antibody which could coat the cell and permit antibody dependent 
lymphocyte cytotoxicity.
However, both mechanisms require interaction with the target 
cell membrane and yet the classic ICA gives intracytoplasmic and not 
cell membrane staining (Kaldany, 1979). It is, therefore, difficult 
to understand their role in the pathogenesis of islet cell damage by 
cytotoxic mechanisms.
In this study, islet cell antibody was further investigated 
using various putative antigens in absorption experiments. The re­
sults obtained from 4 juvenile-onset, insulin-dependent diabetics, 
strongly positive for ICAs, are shown in Table 5.4. The increased 
intensity of fluorescence on absorption with pancreatic homogenate 
suggests that a factor in the serum that was inhibiting the binding 
of ICAs to the section was being absorbed cut. The decreased 
fluorescence seen on absorption with Coxsackie B^ virus may be caused 
by the antibody reacting with antigenic determinants common to both
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the virus and the islet cell. This might provide an explanation for 
the possible mechanism of the virus causing 8-cell destruction by an 
autoimmune process.
These preliminary results await confirmation by a more quan­
titative technique. This could possibly be achieved by noting the 
antibody titre prior to and after absorption. Alternatively, it may 
be possible to quantitate ICAs by using other techniques for their 
estimation, e.g., immunoprécipitation procedures with a presumptive 
antigen.
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CHAPTER VI.
HLA Antigens in Juvenile Diabetics and Family Studies.
Introduction
The major histocompatibility complex is a system of closely linked 
multiple genes on the short arm of chromosome number six, which in man 
is known as the HLA region. The complex includes the A, B, and C loci 
which control cell surface glycoproteins and are detectable serologic­
ally, and a D locus which is believed to control cell surface antigens 
that may be detected in mixed lymphocyte reactions. Other loci in the 
complex include those controlling various components of complement (Ed. 
B.M.J., 1976).
The A, B, and C loci are not directly involved in the immune re­
sponse but are closely linked to other loci within the major histo­
compatibility complex that are responsible for immune responses (Ed. 
Lancet, 1976). According to Svejgaard and Ryder (1976), the HLA system 
controls strong alloantigens, many immune responses, and some compo­
nents of the complement cascade.
The major histocompatibility system of man is shown on the fol­
lowing page.
Cudworth (1978) suggests that many genes in these chromosomal 
regions probably control differences in immune response and therefore 
differential susceptibility to a variety of diseases. The HLA anti­
gens almost certainly act as markers for the existence of immune re­
sponse genes which are in linkage disequilibrium with the HLA system.
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DR.
DRW 1 
DRW 2 
DRW 3 
DRW 4 
DRW 5 
DRW 6 
DRW 7
l l l l l
Bf : C AAw
DW 1 B 5 cw 1 A 1
DW 2 B 7 cw 2 A 2
DW 3 B 8 cw 3 A 3
DW 4 B12 cw 4 AID
DW 5 B13 cw 5 All
DW 6 B14 cw 6 AW19
DW 7 B15 AW23
DW 8 B16 AW24
DW 9 B17 AW25
DWIO B18 AW26
DWll BW21 AW28
BW22 AW29
BW27 AW30
BW35 AW31
BW37 AW32
BW38 AW33
BW39 AW34
BW40 AW36
BW41 AW43
Immune response genes have been found in guinea pigs and mice which 
are closely linked to the H2 system, Rosenberg and Kidd (1977) state 
that by analogy with mice, the HLA complex probably contains addi­
tional loci which control responses to specific antigens, and immune 
associated loci which code for surface antigens found on different 
lymphocyte populations.
There are many mechanisms whereby such genes may operate in 
association with the major HLA antigens to confer susceptibility to 
certain diseases. Many reports of associations of various diseases 
with HLA antigens have been published. A list of some of the posi­
tive associations between HLA antigens and disease is shown here 
(Hobart and McConnell, 1975).
Hodgkin's disease
Acute lymphatic leukemia
Ankylosing spondylitis 
Graves disease
HLA-B5
HLA-Al
ELA-B8
HLA-A2
HLA-B12
HLA-BW27
HLA-B8
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Coeliac disease HLA-B8
Myasthenia gravis HLA-B8
Chronic active hepatitis HLA-B8
Systemic lupus erythematosis HLA-B15
Multiple sclerosis HLA-A3
HLA-B7
Almost all associations are with the second locus of the HLA 
system, i.e., the B locus or in Mannick's (1973) terminology the four 
or second sublocus. Diseases showing an association with B locus 
antigens tend to be male predominant and sometimes show indirect evi­
dence of bacterial infection, whilst some diseases with a relatively 
weak association with B locus antigens have now been shown to have a
closer association with the D locus and are often female predominant
with suspicion of a latent virus infection (Ed. B.M.J., 1976).
Bodmer and Bodmer (1974) propose four mechanisms to account for 
associations between HLA antigens and disease. Thus:
1. HLA antigens might induce tolerance to foreign antigens with 
which they cross-react, including antigens which are components of a 
viral pathogen.
2. HLA antigens may serve as receptors, or interact with re­
ceptors, for specific viruses.
3. Pathogenic agents might incorporate into their coat a por­
tion of membrane from the cell which they are attacking that carries 
HLA antigens.
4. Immune response genes linked to HLA genes can provide the 
basis for disease associations. Diseases showing the most signifi­
cant association with the HLA complex are autoimmune and therefore 
this mechanism seems most likely.
In addition to the mechanisms proposed above, there is the pos­
sibility that a structural similarity between certain HLA antigens
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and hormone receptors may result In competitive binding with the hor­
mone being absorbed onto the wrong receptors (Svejgaard and Ryder, 
1976). This idea is supported by the work of Naj sky and Jakoubkova 
(1976) who found a transient loss of HLA antigens on lymphocytes 
during menstruation and during ovulation, whilst in the intermittent 
period the HLA antigens were consistently demonstrated. They con­
cluded that the HLA antigens on the lymphocytes were masked or blocked 
by hormones.
Tauber (1976), however, states that all recognition is based 
on a comparison with an appropriate standard and that on a molecular 
level markers of biological individuality become the very receptors 
for immunological recognition, serving as a direct standard against 
which foreigness can be measured and therefore no special mechanism 
is needed to explain HLA and disease association.
McDevitt and Bodmer (1974) support the idea of immune response 
genes linked to HLA genes, stating that disease association can be 
interpreted in terms of the effects of genes in the HLA region which 
control immune responses that are critical for disease susceptibility. 
HLA linked specific immune response genes are most probably impor­
tant genetic factors predisposing to resistance or susceptibility to 
a variety of neoplastic, autoimmune, and infectious diseases in man. 
McDevitt and Bodmer (1974) believe that the disease associations are 
the result of HLA linked immune response genes and explain that the 
associations are not absolute for the following reasons:
1. If environmental factors are involved, then not all indi­
viduals with the right genotype will necessarily be exposed. The 
effect of the genotype may be "all or none," i.e., not fully pene­
trant, but may interact with the level of environmental exposure.
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2. The disease in question may be heterogeneous and have more 
than one aetiology.
3. Other genes, not linked to the HLA system, may be involved 
in disease susceptibility.
4. If the whole effect is due to one or more loci closely 
linked to those determining HLA antigens, recombination may disrupt 
the antigen association.
The association of disease with HLA specificities is usually 
expressed as relative risk which is defined as the ratio of the risk 
of development of the disease in those with the antigen divided by 
the risk in those lacking it (Rosenberg and Kidd, 1977).
Diabetes mellitus is believed to be a genetically determined 
disorder (Singal et al., 1973) in which inherited susceptibility 
plays an important part. Singal et al. (1973) found that the fre­
quency of HLA-B15 was significantly increased in insulin-dependent 
patients than in insulin-independent diabetics and control subjects. 
Nerup et al. (1974) found an increase in HLA-B8 and HLA-B15 in dia­
betics. HLA-B8 was increased in juvenile diabetics but not in the 
maturity-onset diabetics, whilst HLA-B15 was increased in both groups 
The same workers stated that there is a 2-3 times higher chance of 
developing insulin-dependent diabetes if a subject is HLA-B8 or HLA- 
B15 positive compared to an individual lacking these antigens. 
Cudworth and Woodrow (1974) typed 100 patients and found HLA-B8 was 
present in 54% of juvenile-onset diabetics compared with 31.8% of 
maturity-onset diabetics, and HLA-B15 was present in 18% and 12%, 
respectively. When their data were combined with that of Nerup et 
al. (1974) and Finkelstein, Zeller and Walford (1972), the relative 
risk for juvenile-onset diabetes was 2.41 for individuals possessing
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HLA-B8 and 2.34 for those with HLA-B15*. In a further study, Cudworth 
and Woodrow (1975) tested 150 diabetic patients with an age of onset 
less than 30 years and 68 diabetic patients where onset was over 30 
years of age and again they found differences in the frequencies of 
HLA-B8 and HLA-B15 when compared to 300 control subjects. They com­
bined their results with some from Copenhagen and found a relative 
risk of 2.4 for HLA-B8 and 2.09 for HLA-B15. The relative risk for 
individuals possessing both antigens was 4.67. The frequencies of 
these two antigens in maturity-onset diabetics were not significantly 
different from those found in control subjects. Maturity-onset dia­
betes is not HLA linked but has a strong hereditary tendency whereby 
60% of children of two such diabetics will develop the disease by the 
age of 60 years (Ed. B.M.J., 1975).
In a study of 288 juvenile-onset diabetics of 30 years or less 
at diagnosis, Cudworth and Woodrow (1976) found relative risks for 
HLA-B8, HLA-B15, and HLA-B18 were 2.54, 2.0, and 2.4, respectively. 
They also showed a negative association with HLA-B7 and low relative 
risks for individuals possessing HLA-B5 and HLA-BW35. The combined 
relative risk for patients possessing antigens HLA-B8 and HLA-B15 was 
5.4. In addition, they found a significantly increased frequency of 
HLA-B8 in late-onset diabetics who were insulin-dependent and normal 
frequencies in insulin-independent diabetics. Further studies have 
confirmed the increased frequencies of HLA-B8, HLA-B15, and HLA-B18 
(Langraf et al., 1976; De Moerloose et al., 1978; Cudworth, 1978) 
but Rubinstein et al, (1976) stated that HLA antigens, B8 and B15, 
are doubtful or non-existent in populations other than those studied 
in England or Denmark, and they suggested that the HLA system is not 
directly involved in diabetes, but that it maintains linkage
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disequilibrium with nearby genes that are more important. Bottazzo 
and Doniach (1976) concluded that testing for the lymphocyte marker 
DW3 gives a better correlation of the "autoimmune" gene since it 
might be closer to the immune response genes, and Rubinstein et al. 
(1976) stated that the association of diabetes with DW3 is greater 
than those of HLA-B8 and HLA-B15, Cudworth (1978) reported a study 
of 323 insulin-dependent diabetics with an age of onset less than 30 
years and found an increased relative risk of developing diabetes 
was observed in patients who were HLA-Al, A2, B8, B18, B15, B40,
CW3, Bf®, DW3, DW4, DRW3, and DRW4 positive. A significant associa­
tion was found in the frequency of CW3 compared to controls, but a 
stronger association was demonstrated with HLA-DW3 and DW4 specifici­
ties which gave a relative risk of 6.4 and 3.7, respectively (Nerup 
et al., 1976; Cudworth, 1978). A positive association between juve­
nile-onset diabetes and DRW3 and DRW4 was suggested by Cudworth 
(1978) and a negative association with DRW2. De Moerloose et al. 
(1978) found the most significant association of HLA antigens and 
diabetes was with DRW3 which gave a relative risk of 9.2 compared to 
2.9 for HLA-B8. Cudworth (1978) proposed the following pattern of 
susceptibility and protective HLA factors in type I (juvenile-onset 
diabetes:
Susceptibility ^ P r o t e c t i o n
DRW3 DRW4 ^ 
DW3 DW4 -
DRW2
DW2
Immune response genes
B8 B15 ■■' B7
B18 B40
CW3
A1 A2 — All
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The present study was designed to ascertain whether similar 
disturbances in HLA antigen frequency could be found in the popula­
tion of diabetic patients in the Bath area. Family studies were also 
undertaken to determine whether possession of particular antigens gave 
an increased disposition to the disease.
Patients and Methods
HLA phenotyping. Ninety-six juvenile-onset type diabetics were 
screened for their HLA type. Two groups of control subjects were 
used in this study. These were (a) 417 healthy, non-selected people 
from the same geographical area tested over the same period of time 
by the same laboratory and (b) 66 maturity-onset type diabetics who 
also complied with the above criteria.
HLA genotyping. HLA genotypes were obtained for 28 of the juvenile 
diabetics by a study of the HLA types of their families. In these 
leases, family histories were taken and when possible the proband, 
his siblings, both diabetic and non-diabetic, were HLA typed. This 
was done to determine whether in the respect of the affected sib­
lings, one, both, or neither of the HLA haplotypes were identical.
HLA typing. HLA typing was performed by the National Tissue Typing 
Reference Laboratory, Southmead, Bristol. Nine A locus and seventeen 
B locus antigens were tested. The significance of disburbances in 
the frequencies of these antigens were assessed by the Fisher Irvin 
exact chi-square test.
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Results
Four HLA antigens, HLA-B8, B15, B18, and BW40 appeared with an 
increased frequency in the juvenile-onset diabetics as compared with 
the maturity-onset diabetics and control subjects. The increased 
frequency and relative risk for HLA-B18 and HLA-BW40 were not sig­
nificant. The increase in HLA-B8 and B15 was significant with the 
antigens running either independently or together (Table 6.1).
Table 6.1. Frequencies of HLA antigens in juvenile-onset diabetics, 
maturity-onset diabetics, and control subjects
HLA Antigens
Control Subjects 
N = 417
Juvenile 
Diabetics 
N = 96
Maturity-onset 
Diabetics 
N = 66
B8
B15
B8, B15 
B7
Al, B8
108 (26%) 
54 (13%) 
16 (3.8%) 
117 (28%) 
92 (22%)
48 (50%)*
25 (26%)*
17 (17.7%)** 
10 (10.4%)* 
43 (45§)**
18 (27%)
6 (9.1%) 
0 ( 0%) 
22 (33%) 
16 (24%)
*0.01 > P > 0.001.
**0.001 > P.
The haplotype HLA-Al, B8 was also significantly increased, 
whilst the antigen HLA-B7 was decreased. The relative risk statis­
tic (Svejgaard et al., 1974) showed that HLA-B8 and HLA-B15 positive 
individuals carry an increased risk of developing the disease of 
2.86 and 2.37 times, respectively, whilst the combined risk for HLA- 
B8 and B15 positive individuals is 4.4. HLA-B7 positive individuals 
and those carrying the HLA-Al, B8 haplotype were calculated to carry 
relative risks of 0.30 and 2.86, respectively.
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Over the course of the study more cases were recorded during 
autumn and winter months than in the spring or summer (Table 6.2). 
These results, however, present no evidence of clustering of cases 
associated with any particular HLA phenotype.
When the patients were examined by age categories (Table 6.3), 
it appeared that school age children were most likely to contract 
the disease, with the suggestion of a second peak in the early 
twenties. The possession of HLA-B8 may be conferring an increased 
susceptibility on this latter group, but no other age group showed 
any association with a particular phenotype.
HLA and Families. Genotypes of the four families with two or more 
diabetic siblings are shown in Table 6.4. It showed that in each 
of the three families with two affected siblings, the diabetic sib­
lings each shared both haplotypes; in the families with a third un­
affected sibling, one shared both and the other neither haplotype 
with their respective affected siblings. In the family with three 
affected siblings, two had both haplotypes identical and the third 
shared one with these two and the other haplotype with the fourth, 
unaffected, sibling.
In 20 families, HLA genotypes of the propositus were also com­
pared with those of his siblings, both diabetic and non-diabetic 
(Table 6.5). These families included 16 sibships with one diabetic 
child and four with two or more diabetic children. If the first 
family member affected is considered as the index case for each sib- 
ship and is excluded from the table, the rest of the siblings are 
assorted as shown.
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Table 6.4. Genotypes of four families with two or more diabetic 
siblings.
Family Diabetic sibling Non-diabetic sibling
1 JB
AB
Al, B8/A2, B15 
Al, B8/A2, B15
UB Al, B8/A2, B15
2 OS
NS
Al, B8/A9, B27 
Al, B8/A9, B27
3 KF
DF
A2, B15/A2, B15 
A2, B15/A2, B15
SF A2, B7/A2, B21
4 GJ
LJ
KJ
A9, B15/A1, B8 
A9, B15/A1, B8 
A9, B15/A3, B7
SJ A3, B7/A3, B7
Table 6.5. HLA identity and type I diabetes in siblings of 
propositus
HLA Identity Diabetic Non-diabetic Totals
Identical 4 9 13
Non-identical 1 19 20
Totals 5 28 33
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Four of 13 (31%) HLA identical siblings were themselves dia­
betic, where only 1/20 (5%) of the non-identical siblings were dia­
betic. This difference did not achieve statistical significance 
(0.10 < p < 0.50).
Discussion
In the present study the previous findings of Nerup et al.
(1974), Cudworth and Woodrow (1974 and 1975) were confirmed. An 
increased frequency of the antigens HLA-B8 and B15 and the haplotype 
HLA-Al, B8 were found in juvenile-onset diabetics. The protective 
value conferred by the presence of the antigen HLA-B7 was also con­
firmed (Cudworth and Woodrow, 1976). The relative risk statistic 
shows that HLA-B8 and HLA-B15 positive individuals carry a 2.8 and 
2.4 increased chance of developing diabetes. This is in agreement 
with the figures presented by Cudworth and Woodrow (1975). Individ­
uals positive for both HLA-B8 and B15 carry an additive risk.
In agreement with Nerup et al. (1976) there was no disturbance 
in the frequencies of these antigens in the population of maturity- 
onset type diabetes studied, thus emphasising the evidence for 
genetic heterogeneity and the different pathogenic processes which 
are involved in the two major clinical forms of diabetes.
Thus, HLA studies indicate that there is no simple association 
between HLA and this disease, as apparently occurs in the case of 
coeliac disease which shows a strong relationship with HLA-B8. In 
the case of juvenile-onset insulin-dependent diabetes, the B locus 
studies, strengthened by the evidence from mixed lymphocyte culture 
(D locus) typing that DW3 and DW4 both confer on increased risk of 
the disease, suggest that two HLA linked genes confer susceptibility- 
Further evidence that more than one HLA linked gene, possibly
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operating by a different pathogenetic mechanism in juvenile-onset dia­
betes, is the finding that the relative risk is additive when both B8 
and B15 are present. Cudworth and Woodrow (1976) quoted evidence 
that the relative risk is higher for those individuals homozygous 
for B8 than those who are heterozygous, but not as high as that for 
individuals possessing both HLA-B8 and B15 antigens. This may indi­
cate that the risk of developing juvenile-onset diabetes is not addi­
tive when the gene operating via one particular mechanism is inherited 
on both HLA chromosomes, in contrast to when two diabetogenic genes 
are inherited. Rubinstein, Suciu-Foca, and Nicholson (1977) disagree 
that these two genes have different mechanisms as shown by the addi­
tive effect. They state that the disease is inherited as a recessive 
trait with a penetrance of about 50%. However, Neel (1977) points 
out that whenever incomplete penetrance is introduced, it is often 
impossible to clearly distinguish between multifactorial, dominant, 
recessive, simple one-locus additive and overdominant inheritance. 
Cudworth (1978) quoted several investigators who proposed autosomal 
recessive inheritance but with the postulation that penetrance is 
markedly reduced such that only about one-fifth of the subjects with 
the genotype actually develop the disease. Cudworth, however, be­
lieves that it is unlikely diabetes would be controlled by a single 
gene and that by invoking incomplete penetrance of this magnitude, it 
is possible to prove almost everything has a genetic basis.
Rubinstein et al. (1976) and Suciu-Foca and Rubinstein (1976) 
also reported that gene cross-over in parents of diabetic children 
was 15-fcld. They postulated that genes for susceptibility must be 
in close proximity to the HLA complex for the linkage to be detected. 
Neel (1977) points out that if there is not an increase in crossing
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over in the parents, the strength of the argument for a recessive 
hypothesis is reduced, and that some type of additive genetic hypo­
thesis involving one or several loci, seems the most likely alterna­
tive for the data presented. Shaw, Kansal, and Catti (1976) sup­
port Rubinstein*s claim and quote the rare event of a bilateral HLA 
recombinant in juvenile diabetes mellitus. They suggest that this 
shows support for an increased frequency of HLA recombinations in 
families of patients with juvenile diabetes mellitus. The results 
presented in this study agree with those of Nerup (1976) and Cud­
worth (1978) that two genes confer susceptibility to diabetes upon 
the individual.
The finding that when one member of an identical twin pair was 
diabetic and the other was affected in 50% of the twin pairs (Nelson 
et al., 1975) suggests that whatever the genetic predisposition to 
the disease may be, it finds its clinical expression in about half 
those who are predisposed, i.e., there is a 50% penetrance of the 
genotype and leads to the likelihood that the relative aetiological 
importance of genetic and environmental factors is different in the 
two groups where juvenile diabetes is concerned. Nelson et al. (1975) 
stated that if no difference was found in the frequencies of HLA-B8 
in concordant and discordant twins, then the concept of a single 
major HLA-linked gene causing susceptibility is supported and devel­
opment of the disease would depend on an environmental factor in in­
dividuals possessing this gene.
There are three potential principal causes of an association of 
type I diabetes with an HLA antigen. These are as follows:
1. Ethnic stratification, i.e., both the disease and the HLA 
type are common in the ethnic group under study. This is an unlikely
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explanation as the reports of HLA disturbances come from diverse 
centres.
2. Causation, i.e., the HLA type is in a direct chain of 
events leading to the disease. The fact that many diabetics pre­
sent without the suspected antigens militates against this.
3. Association, i.e., the. HLA alleles are linked to one or 
more alleles responsible for a predisposition to the disease.
Family studies are of help in explaining these possibilities. 
In addition, because they exclude artifacts of population structure 
and are not affected by linkage disequilibrium, they may provide 
evidence for simple dominant or recessive inheritance of suscepti­
bility (Rosenberg and Kidd, 1977). If the major susceptibility is 
dependent on the inheritance of an HLA-linked gene, then it would be 
expected that affected siblings would always be identical for one or 
both HLA haplotypes unless a cross-over or recombination had occur­
red during meiosis. Cudworth and Woodrow (1975) present strong 
evidence that this is so by demonstrating in HLA A and B haplotype 
studies that diabetic siblings usually inherit at least one haplo­
type in common.
Recombination events during meiosis are rare between various 
HLA loci, so that identification of HLA A and B haplotypes probably 
indicates inheritance of the maternal and paternal HLA chromosome 
regions en bloc. In the present analysis of family genotypes, 4/5 
pairs of diabetic siblings possess two identical haplotypes. As the 
chances of two random siblings having two identical phenotypes are 
only 25%, this figure indicates a trend to autosomal recessive trans­
mission.
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A more specific genetic hypothesis advanced by Rubinstein et 
al. (1977) suggests that type I diabetes is due to a recessive gene
closely linked with HLA-D and with 50% penetrance. If this is so,
the first affected child with a sibship should be homozygous for a 
gene close to HLA and the rest of the sibship should fall into two
categories from the point of view of the susceptible gene:
1. HLA identical to the first affected and homozygous for the 
gene closely linked to the susceptibility gene.
2. HLA non-identical, i.e., sharing with him either one or 
neither of the carrier haplotypes. This category includes children 
heterozygous for the gene and the children who lack it altogether.
Analysis of the results in this study on the basis of HLA A/B 
haplotypes (Table 6.5) failed to support this hypothesis.
The mode of transmission of a susceptibility gene remains ob­
scure, but it seems probable that such a gene would mediate interac­
tion with environmental factors such as viruses that have potential 
cytopathic effects on the 3-cells of the pancreas. Despite lack of 
evidence of viral initiation of the disease obtained by study of 
viral antibody titres (Gamble et al., 1969 and 1973), the finding of 
lymphocytic infiltration of the islets of Langerhans* in newly diag­
nosed type I diabetes (Gepts, 1965) could be in keeping with viral 
damage.
An alternative hypothesis is that HLA-linked genes control im­
mune responsiveness to viruses which have a potentially cytopathic 
effect on the 3-cells of the pancreas. A role for the immune re­
sponse can also be invoked if there were any cross-reaction between 
viral and pancreatic antigens.
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CHAPTER VII.
Immunological Features of Juvenlle-Onset Diabetic Patients
Correlated to HLA Type.
Introduction
Any explanation of the aetiology of juvenile-onset, insulin- 
dependent diabetes mellitus (type I) must include the direct experi­
mental evidence of organ specific autoimmune phenomena that are asso­
ciated with this condition. Antipancreatic cell mediated immunity 
has been reported (Nerup et al., 1971; MacCuish et al., 1974;
Richens, Ancill, and Hartog, 1976) in diabetic patients against vari­
ous pancreatic antigens and liver mitochondria. This has been de­
scribed more fully in Chapter III. Also a transient IgG antibody 
against pancreatic islet cells has been demonstrated in the early 
stages of disease in these patients (Lendrum et al., 1975; Irvine et 
al., 1977 .; Bottazzo et al., 1976) and to occur more persistently in 
diabetic patients with additional endocrinopathies (Bottazzo et al., 
1974; MacCuish et al.; 1974). Bottazzo et al. (1974) first described 
persistent ICAs in patients with polyendocrine disease and their re­
sults were supported by MacCuish et al. (1974). Subsequently, anti­
bodies to islet cells were detected in 50% of young, recently diag­
nosed juvenile-onset type diabetics (Lendrum et al., 1975; Irvine 
et al., 1977). In addition, MacLaren et al. (1975) have reported 
that a high proportion of sera from patients with juvenile-onset
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diabetes have been shown to react with a cell surface antigen in 
suspensions of viable cells from a human insulinoma maintained in 
prolonged tissue culture; this probably represents a distinct anti- 
gen-antibody system. The significance of these antibody markers in 
the aetiology of juvenile-onset diabetes remains uncertain.
Additional evidence of autoimmunity in this condition is seen 
in animal experiments where it is found that immunisation with 
homogenates of isolated islets of Langerhan*s can induce a transient 
diabetic state (Nerup et al., 1974a) producing decreased glucose 
tolerance, cell-mediated immunity against the endocrine pancreas, 
discrete lymphocytic infiltration of the islets of Langerhan*s, and 
3-cell destruction.
Of further interest is the depression of phytohaemagglutinin 
transformation of lymphocytes in diabetic patients which reflects 
the state of cell-mediated immunity (MacCuish et al., 1974b). How­
ever, MacCuish et al. conclude that the depression of lymphocyte 
transformation in these diabetics is indicative of poor control of 
the disease, i.e., a metabolic disorder as opposed to an inherent 
altered T-cell reactivity.
In addition to these factors the importance of environmental 
factors in the onset of this type of diabetes must be recognised.
Thus, a bimodal age of onset in those cases below sixteen years of 
age (Gamble and Taylor, 1976) and a seasonal variation in frequency 
of new cases (Bloom et al., 1975) suggest viral factors, especially 
Coxsackie B^ against which high titres of neutralising antibodies 
have been demonstrated in the sera of juvenile-onset diabetics 
(Gamble et al., 1969 and 1973). However, there is no evidence for 
viral initiation of the disease and results of immunising experimental
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animals with virus are variable (Ed. Lancet, 1976). These two lines 
of evidence are reconciled by theories that suggest that in genetic­
ally susceptible individuals a defective immunological response 
against environmental (viral) factors leads to 3-cell destruction 
either directly or through autoimmune processes (Cudworth and 
Woodrow, 1975). It is possible that such a genetic susceptibility 
may be bestowed by genes associated with HLA antigens. As previously 
described in Chapter VI, these patients show an increased frequency 
of HLA-B8, B15, and HLA-DW3 and DW4 antigens (Nerup et al., 1974;
Cudworth and Woodrow, 1975; Thomsen et al., 1975).
It is important to know how these three factors, autoimmunity, 
environment and genetic susceptibility interact. In this study juve­
nile diabetics have been HLA typed and the occurrence of these anti­
gens correlated with islet cell and other autoantibodies, and immune 
phenomena.
Materials, Methods and Subjects
HLA Phenotyping. Ninety-six juvenile-onset type diabetics were 
screened for their HLA type as described in Chapter VI.
Leucocyte Migration Test. In 49 patients with juvenile diabetes, the 
incidence of cell-mediated immune reactions were investigated using 
the leucocyte migration test as described in Chapter III.
PHA Transformation. Ten patients with juvenile diabetes were tested 
for lymphocyte transformation as described in Chapter IV.
Autoantibody Identification. Fifty-four juvenile-onset type diabetics 
were studied for the presence of ICAs and of thyrogastric, mitochondrial.
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smooth muscle, reticulin, and antinuclear antibodies as described 
previously in Chapter V.
Results
Sera from 17 of the 54 (32%) juvenile-onset type diabetics 
showed the presence of ICAs. The mean duration of diabetes for the 
whole group was 4 years 11 months (range 1 week - 20 years). When 
the patients were subdivided into groups according to the duration 
of disease, 12/17 (70%) of those within 1 year of onset, 5/18 (28%) 
of those between 1 and 5 years* duration, 0/19 of those greater than 
5 years* duration were positive for ICAs. With the small numbers 
available, no alterations in the prevalence of ICAs could be 
discerned with the age of the patients. Thus, in those patients 
examined within 1 year of diagnosis, 2/3 between the ages of 5 and 
10 years, 4/6 between the ages of 11 and 15 years, 2/3 of those be­
tween 15 and 20 years, and 4/5 of those more than 20 years were posi­
tive for ICAs. There was no apparent association between HLA type 
and the presence of ICAs (Table 7.1). Furthermore, examination of 
the haplotypes of the 17 patients who were ICA positive revealed no 
advantage in possessing both HLA-B8 and B15 (1/17) or being 
homozygous for B8 (0/17) and B15 (1/17) compared with B8, x (7/17) 
or B15, X  (2/17) heterozygotes.
The sera of 53 of these patients were examined for the pres­
ence of other circulating antibodies; 33 were found to be positive 
in this respect. Of these 33 sera, 12 were positive for gastric 
parietal call antibodies, 12 for thyroid antibodies and 18 for non­
organ specific antibodies. The mean age of these patients was 23.8 
years and the mean duration of disease was 5 years 2 months, and 11
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Table 7.3. Mean migration indices obtained for groups of insulin- 
dependent juvenile diabetics with Coxsackie B4, pan­
creatic and mitrochondrial antigens.
HLA Type
Mean Migration Indices (± S.D.)
Coxsackie B4 Mitochondria Pancreas
HLA B8 0.99 + 0.18 (15) 0.78 + 0.17 (24) 0.85 + 0.11 (17)
HLA B15 0.91 + 0.18 ( 5) 0.79 + 0.12 (12) 0.74 + 0.06 ( 6)*
B8 + B15 0.96 + 0.08 ( 2) 0.81 + 0.12 ( 7) 0.77 + 0.08 ( 4)
Not B8, B15 0.94 + 0.21 (18) 0.84 + 0.21 (24) 0.84 + 0.09 (15)
*Students t values sig. diff. (0.02 < p < 0.05).
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(33%) were also ICA positive. The remaining 20 patients did not pos­
sess other circulating autoantibodies. Their mean age was 23.4 years 
and their mean duration of disease was 3 years and 10 months and 5 
(25%) were ICA positive. Table 7.2 shows the frequencies of HLA-B8 
and B15 and of HLA-Al, B8 in patients with and without circulating 
autoantibodies. ICAs were not studied for a long enough period to 
determine whether or not there was an association of thyroid and gas­
tric antibodies with persistent ICAs.
Forty-nine of the insulin-dependent diabetics were tested for 
cell-mediated hypersensitivity reactions against human pancreas 
preparations, rat liver mitochondria and particles of Coxsackie B4 
virus. The mean migration indices for each antigen were calculated 
according to HLA antigen status. HLA-B15 patients showed a signifi­
cant depression of migration index with the pancreatic antigen com­
pared to patients who possessed neither HLA-B8 or B15. No further 
correlation was found between migration index and HLA phenotype. 
Neither was there any correlation between a positive cellular hyper­
sensitivity reaction and the presence of ICAs.
No relationship was found between PHA responsiveness and HLA 
antigen status. Only 10 diabetic patients were tested and of these 
two showed a depression of lymphocyte transformation. With numbers 
as small as this, it is impossible to make any associations.
Discussion
The finding of an overall incidence of islet cell antibodies 
in 32% of juvenile-onset type diabetics when no allowance was made 
for the duration of disease is similar to the findings of other in­
vestigators (Irvine et al., 1977a; Bottazzo et al., 1976; Nerup et
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al., 1976). Because of the transient nature of ICAs, it is not sur­
prising that no association was found with HLA antigens. Secondly, 
if, as is suspected, that all juvenile-onset type diabetics possess 
ICAs at some stage before the onset or for a short time after the on­
set of disease, then the HLA association would be of no value because 
it would merely reflect the number of diabetics possessing a particu­
lar HLA type. The findings presented here show that 7/20 ICA posi­
tive diabetics possessed HLA-B8, 3/5 possessed HLA-B15 and neither of 
these figures was significantly different from the incidence of 6/20 
ICA positive patients with all other HLA types tested.
Associations between the persistence of ICAs, the presence of 
other circulating autoantibodies, and HLA-B8 have been previously re­
ported (Christy et al., 1976; Irvine et al., 1977). The data pre­
sented here are insufficient to support this. However, there was a 
significant association between HLA-B15 and the presence of other cir­
culating autoantibodies that occur in type I diabetics. HLA-B15 also 
appeared to be associated with a positive migration index with pan­
creatic antigen. Thus, two immunological features showed a connection 
with HLA-B15.
The findings presented support other evidence (Christy et al., 
1976) that circulating ICAs do not appear in conjunction with cellu­
lar immune reactions. A similar lack of correlation is seen in other 
autoimmune endocrine disorders such as idiopathic Addison*s disease 
(Nerup and Bendixen, 1969; Platz et al., 1974) that, like type I dia­
betes, is associated with HLA-B8 (Thomsen et al., 1975).
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CHAPTER VIII.
Investigation of the Role of Cytotoxic Lymphocytes in 
Insulin-Dependent Diabetes Mellitus.
Introduction
Cell-mediated tissue injury is believed to be an essential com­
ponent of delayed hypersensitivity, of some experimental and human 
autoimmunities, of various allograft phenomena, and of some forms of 
tumour rejection. Sensitised lymphoid cells will destroy tissue cul­
ture cells possessing the antigen to which the cells are sensitised. 
Perlmann and Holm (1969) state that this type of reaction has been 
found in all the situations mentioned above.
Cytotoxic reactions can be divided into three categories. The 
first is a specific reaction, the target cells possessing the antigen 
to which the donor is sensitised. The second type is cellular non­
specific, cytotoxicity being induced by humoral antibodies to target 
cell antigens. The third type is also non-specific where cytotoxicity 
is induced by a variety Of agents known to stimulate lymphocytes to 
blast formation and DNA synthesis.
Perlmann and Holm (1969) reviewed the subject and suggested some 
in vivo correlates to the various cytotoxic actions described:
1. Delayed hypersensitivity where (a) sensitised lymphocytes 
may exert a direct cytotoxic action on antigenic constituents of tis­
sue cells, or (b) sensitised lymphocytes may become activated by
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interaction with antigen leading to nondiscriminatory injury of sur­
rounding tissue cells, or (c) free antibody-antigen complexes on the 
surface of macrophages may be formed if humoral antibodies are pres­
ent, or locally produced in some delayed reaction. These may stimu­
late and induce a cytotoxic action in a certain fraction of non­
sensitised lymphocytes. Antigenr-antibody complexes on tissue cells 
may lead to direct destruction of tissue cells by activation of non­
sensitised lymphocytes through the Fc receptor attachment.
2. Autoimmunity. This is usually recognised by the presence 
of humoral autoantibodies. However, the pathogenic role of these 
antibodies in most diseases is unknown. Cell-mediated immune reac­
tions are considered to be instrumental in the production of tissue 
lesions in certain autoimmune diseases. Cell-mediated destruction of 
tissue culture cells has been described for several human and experi­
mental autoimmunities. Co-existing humoral antibodies may act 
synergistically or antagonistically to the cellular mediators. Anti­
bodies may participate in the production of experimental allergic 
encephalitis by exerting cytolytic reactions in conjunction with com­
plement or by interacting with lymphoid cells in antibody-induced 
cytotoxicity.
3. Graft-versus-host reactions where interactions between donor 
and host lymphoid cells may produce activated lymphoid cells which may 
provoke tissue lesions by the same mechanism that occurs when lympho­
cytes are stimulated in mixed culture.
4. Allograft rejection by cell-mediated reactions may be in­
duced by small amounts of antibodies to transplantation antigens. 
Antibody might be produced locally in the graft or elsewhere and may 
interact with lymphoid cells infiltrating the graft. It may be that
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sensitised lymphocytes destroy graft cells by a direct cytotoxic 
action. In addition, sensitised cells may recruit nonsensitised 
cells by a reaction with antigen and the release of non-specific 
soluble factors.
5. Tumour defence where a prerequisite for an immune response 
is the presence of tumour-specific antigens which have, in general, 
characteristics of transplantation antigens. The mechanisms de­
scribed for allograft rejection may all be involved in tumour de­
struction.
Govaerts (1960) showed the presence of cytotoxic lymphocytes 
in transplantation reactions and since then cellular immunity to 
tumour allografts has been described by numerous investigators 
(Brunner et al., 1968; Brunner et al., 1970; Canty, Wunderlich, and 
Fletcher, 1971). Non-specific cytotoxicity induced by PHA has been 
investigated by Holm and Perlmann (1967), whilst antibody-induced 
cytotoxicity has been described by MacLennan, Loewi, and Howard
(1969), MacLennan and Harding (1970), MacLennan, Loewi, and Harding
(1970), and Gelfand, Resch, and Prester (1972).
The direct cytotoxic effects observed with lymphocytes from 
sensitised donors have been shown to be due to T-cells (Golstein et 
al., 1972; Cerottini et al., 1971), whilst the presence of T-cells 
is not required for antibody-dependent cell-mediated cytotoxicity 
(Van Boxel et al., 1972; O'Toole, Saxon, and Bohrer, 1977). How­
ever, it has been found that monocytes and macrophages as well as 
certain lymphocytes bind to certain antibody-coated cells (LoBuglio, 
Cotran, and Jandl, 1967; Larsson and Perlmann, 1972; Papamichail 
and Temple, 1975). The antibody-dependent cytotoxic reaction is 
mediated by Fc receptor bearing lymphocytes which are different from
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both T- and B-cells (Froland, Natvig, and Michaelson, 1974). Green­
berg et al. (1973) and Brier, Chess, and Schlossman (1975) concluded 
that antibody-dependent cytotoxic effector activity is a property of 
"null" cells which have no surface markers.
Antibody-dependent cytotoxicity occurs in xenogeneic, allo­
geneic, and autoimmune situations (Perlmann, Perlmann, and Biberfeld,
1972). MacLennan and Loewi (1968) pointed out that antibodies are 
found in a number of disorders for which an autoimmune aetiology has 
been proposed and that the effect of serum antibody on lymphocytes 
might be an important facet of the immunopathological processes of 
these diseases.
Amongst the autoimmune disorders investigated, cytotoxic 
mechanisms have been demonstrated in Hashimoto's thyroiditis. 
Podleski (1972) found that human peripheral lymphocytes from some 
patients were cytotoxic for mouse mastocytoma target cells coated 
with human thyroglobulin or microsomal antigen from thyrotoxic 
thyroid glands. Calder et al. (1973), using thyroglobulin-coated 
chicken red cells as target cells, found that lymphocytes from pa­
tients with Hashimoto's thyroiditis showed greater cytotoxicity than 
those from control subjects. Calder et al. (1976) showed a signifi­
cant increase in K-cell cytotoxic activity in patients with auto­
immune thyroid disease who were newly diagnosed or untreated com­
pared to age and sex matched controls.
In addition to human autoimmune conditions, Ringertz et al.
(1971) showed that lymphocytes from guinea pigs immunised with 
homologous thyroglobulin lysed thyroglobulin-coated chicken red 
blood cells. Sera from these animals rendered lymphocytes from 
normal guinea pigs cytotoxic for thyroglobulin-coated chicken red
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cells. Calder et al. (1974a) showed a similar action with normal 
human lymphocytes in the presence of sera from patients with Hashi- 
moto's thyroiditis.
The purpose of this study was to investigate the possibility 
that cytotoxic lymphocytes might be operative in juvenile-onset, 
insulin-dependent diabetes mellitus. The presence of both direct 
cytotoxic activity (sensitised T-cells) and antibody-dependent (K- 
cell) cytotoxic activity was investigated.
Materials and Methods
Introduction. Some of the problems involved in cytotoxicity assays 
have been reviewed by Perlmann, 1972.
In addition to lymphocytes, macrophages from sensitised donors 
or from normal donors in the presence of small amounts of antibodies 
can attack target cells specifically. The adherent cells are re­
moved by adsorption to glass or nylon columns, or by the feeding of 
colloidal iron. Effector cells (lymphocytes) are then added in great 
excess, but the effects of small amounts of nonlymphocytic cells can­
not be disregarded.
The choice of target cell requires consideration of their 
antigenicity. Other complications are the density of antigenic 
determinants on the target cell surface and the general susceptibil­
ity to lysis of various target cell types depending upon non- 
immunological factors such as membrane properties, growth cycle, and 
metabolic requirements.
Trimarj tissue culture cells have the advantage of natural 
antigenicity but are not well adapted to tissue culture conditions 
and are therefore fragile. Established cell lines are better but
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may have lost some of their original antigens or acquired new ones 
due to viral transformation.
Isotope release from target cells represents the most direct 
assessment of target cell lysis whereas inhibition of incorporation 
may be due to inhibition of active transport of metabolites. This 
may not reflect lysis. When isotope release is measured, there is 
always a background count to be corrected for. The choice of rele­
vant control conditions is critical. Thus, release induced by con­
trol lymphocytes may not always be specific, and release values ob­
tained from lymphocyte-free controls may be misleading since culture 
conditions vary. These problems can usually be overcome when the re­
actions are fast and the initial reaction velocities are measured. 
When incubation is over several days, in vitro sensitisation of 
originally non-immune lymphocytes may occur and increase target cell 
killing in the controls.
Perlmann and Holm (1969 ) note that many different methods are 
used for the assay of cytotoxicity, but these do not measure the 
same reactions and are therefore difficult to compare. All types of 
tissue culture cells may serve as target cells. Where target cell 
antigens are stable in vitro, the culture can be propagated for a 
long time. Some tissue specific antigens, however, disappear within 
one week of culture and studies of cytotoxic reactions in autoimmune 
diseases usually require cultures of freshly explanted tissue.
Chicken erythrocytes have been widely used as target cells and 
when passively coated with antigen, they are excellent targets for 
Jymphoid cells from donors sensitised to that antigen or after re­
action with humoral antibody for lymphoid cells from normal donors.
115
It is essential to start experiments with effector cell sus­
pensions in which 90-100% of the lymphoid cells are viable. Many 
workers have stated that the cytotoxic reaction is dependent upon 
contact between target and effector cell, and that the effector cells 
must be alive and metabolically viable (Granger and Kolb, 1968; 
Perlmann and Holm, 1969).
According to Perlmann and Holm (1969), lymphoid cell suspen­
sions used in most experiments consist of mixtures of lymphocytes, 
monocytes, macrophages, and polymorphonuclear leucocytes and there­
fore to ascribe effector cell function to a specific cell type, it 
is necessary to use an homogeneous suspension. However, it is dif­
ficult to exclude a small number of non-lymphocytic cells especially 
when the number of lymphoid cells added is high. Perlmann, Perlmann, 
and Wigzell (1972) state that previous results indicate that greater 
than 5% of monocytes or polymorphonuclear leucocytes increase the 
initial rate of lysis, but give evidence against monocyte involvement 
where there are less than 0.5% present.
Perlmann and Holm (1969) stated that the best method for measur­
ing cytotoxic reactions is the release of radioisotopes and that 
^^Cr-chromate is an excellent label for the determination of cell- 
mediated lysis of tissue culture cells and of chicken erythrocytes. 
^^Cr is noncovalently bound to proteins and other cell constituents. 
The chromate is reduced in binding and the isotope is not reutilised. 
Some of the criteria for an ideal method to determine cell-mediated 
cytotoxicity are, according to Perlmann and Holm (1969):
1. High sensitivity, to enable detection of cell damage within 
the shortest possible time of incubation.
2. Low error, allowing measurement of small differences.
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3. Quantitative and kinetic measurements of cell damage.
4. Low spontaneous release.
5. That inhibition or promotion of target cell growth by the 
culture conditions does not affect the results.
They stated the best method to be -’^ Cr release which fulfills 
most criteria and can be applied.in most experimental conditions and 
with all types of target cells.
Throughout this work the target cells were chicken red blood 
cells labelled with ^^Cr.
Experimental.
T-cell cytotoxicity. The method used here was based on that de­
scribed by Calder et al. (1973).
Target Cells. 0.5 ml. of chicken blood was taken from the wing 
vein of chicks, aged less than 3 months, into preservative-free 
heparin (Weddell Pharmaceuticals Ltd.) 20 U/ml. The chicken red cells 
were washed three times in phosphate buffered saline (PBS) and ad­
justed to a 2% suspension (0.2 ml. packed red cells made up to 10 
ml. with PBS). Two ml. of this suspension were incubated for 10 
minutes with an equal volume of tannic acid (25 pg/ml.) and the cells 
then washed in PBS. Two ml. of antigen (200 yg/ml.) were added to 
the tanned cells and incubated for 10 minutes. The cells were then 
washed three times in PBS, counted, and adjusted to approximately
g
10 /ml. Of this cell suspension, 0.1 ml. was added to 0.1 ml. of 
sodium ^^Cr-chromate, specific activity 100-300 yc/yg chromium (Radio­
chemical Centre, Amersham, no CJS IP) and incubated for one hour at 
37° C. The cells were then washed three times in PBS, counted, and 
pelletilised until required.
117
The antigens used in these experiments were pancreatic homoge- 
nate, mitochondria or microsomes which were prepared using the method 
described in Chapter III.
Lymphocytes. 20 ml, of venous blood were taken into preserva­
tive-free heparin (20 U/ml.). An equal volume of PBS was added and 
the mixture layered onto a Ficoll-Triosil column and centrifuged at 
400 g. for 20 minutes. The lymphocytes which appear as a band at the 
Ficoll-Triosil/supernatant interface were removed and washed in PBS 
followed by two further washes with culture medium. This consists of 
medium 199 supplemented with antibiotics, glutamine (2 mm. of), and 
10% heat inactivated foetal calf serum.
Adherent cells were removed by incubating the suspension in 
glass bottles for 2 hours at 37° C. The lymphocytes were then counted 
and adjusted to a final concentration of 5 x 10^/ml.
Culture Conditions. 0.5 ml. of the lymphocyte suspension, con­
taining 2.5 X 10^ cells, were pipetted in Sterilin tubes (112 mm. x 
13 mm.) and 1 ml. of the target cell suspension, containing 10^ cells 
was added. This gave a lymphocyte-target cell ratio of 25:1 which 
is frequently used (Biberfeld and Perlmann, 1970; Perlmann and Perl- 
mann, 1970; Perlmann, Perlmann, and Wigzell, 1972; Calder et al.,
1973). In addition, 10^ sheep red blood cells in 0.1 ml. culture 
medium were added to prevent spontaneous lysis (Van Boxel et al.,
1972; Loewi and Temple, 1972). The cell suspensions were cultured 
for 18 hours at 37° C. and then centrifuged at 400 g. for 10 minutes. 
One ml. of the supernatant was removed and counted in a Welltype 
gamma counter. All cultures were performed in triplicate.
Spontaneous release was estimated by measuring cultures con­
taining unlabelled chicken red cells instead of lymphocytes.
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Maximum release was estimated by adding 0.5 ml, of distilled
water to 1 ml. of the target cells, and total activity was esti­
mated by measuring the activity of 1 ml. of the target cells.
Results were expressed as a cytotoxic index proposed by 
Podleski (1972):
Experimental release - spontaneous release ^
Maximum release - spontaneous release
where % isotope release = x 100.
total activity
Patients. Thirteen insulin-dependent diabetics, mean age 28 
years 10 months, were compared with 13 control subjects, mean age
26 years 3 months and were age and sex matched where possible.
K-cell Cytotoxicity.
Target Cells. Chicken red cells were washed three times in
8
PBS, counted, and adjusted to approximately 10 cells/ml., and 
labelled with chromium as described.
Lymphocytes. These were prepared as described previously. 
Culture Conditions. 0.5 ml. of lymphocytes (2.5 x 10^) were 
cultured with 10^ labelled chicken red cells (1 ml.), 10^ sheep red 
cells in a volume of 0.25 ml., and 0.25 ml. of rabbit anti-chicken 
red cell serum previously diluted to 1/1000 and 1/10000 with culture 
medium. These dilutions were decided upon after performing a dose- 
response curve.
Spontaneous release was estimated in tubes where the anti­
chicken red cell serum was replaced by medium but with lymphocytes 
still present. Maximum release and total activity were estimated as 
previously described.
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Results were expressed as specific release: % isotope re­
lease in tube with serum - % isotope release in tube with medium.
Patients. Seventeen insulin-dependent diabetics, mean age 24 
years 1 month,were compared with 17 control subjects, mean age 25 
years 7 months. These were age and sex matched where possible.
Results
T-cell Cytotoxicity. Table 8.1 shows the cytotoxic indices obtained 
from thirteen insulin-dependent diabetics and thirteen control sub­
jects. Figure 8.1 shows the cytotoxic indices obtained when lympho­
cytes were cultured with chicken red cells coated with pancreatic 
homogenate, mitochondria, or microsomes.
Table 8.1. Cytotoxic indices obtained from 13 insulin- 
dependent diabetics and 13 control subjects 
when lymphocytes were cultured with labelled 
chicken red cells coated with a pancreatic 
subcellular fraction.
Cytotoxic Index
Expt. No. Diabetic Control
1 -0.17 -0.17
2 0.00 -2.30
3 0.15 -2.10
4 1.18 2.70
5 12.20 0.00
6 12.30 0.15
7 0.45 4.30
8 1.70 1.40
9 -0.19 -0.76
10 -9.40 -12.00
11 -4.50 -4.00
12 -1.50 -3.20
13 -3.10 -15.00
Mean 0.72 -2.38
The negative values obtained were due to the spontaneous release be­
ing higher than the release obtained in either the test or control
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cultures. Thus, large differences obtained when both values are nega­
tive must be considered void.
In only two cases, number 5 and 6, were there any appreciable 
differences between the cytotoxic indices obtained from using lympho­
cytes from diabetic patients and control subjects. In these two 
cases the diabetic cytotoxic indices were 12.20 and 12.30, respec­
tively, compared to control cytotoxic indices of 0.00 and 0.15, re­
spectively. In both cases the target cells were coated with pancre­
atic homogenate (Fig. 8.1). Patient 5 was a newly diagnosed diabetic 
whose sera was positive for islet cell autoantibody, whilst patient 6 
had become diabetic 6 years previously and was negative for islet 
cell autoantibody.
In all these experiments, the spontaneous release was rarely 
above 20% and in the majority of cases was approximately 10% of the 
total activity. Maximum release corresponded to 70-90% of the total 
activity.
In addition to these experiments, a further test was performed 
to verify Calder et al. (1973) results and ensure that the target 
cells were being adequately coated. Lymphocytes from a patient with 
Hashimoto's thyroiditis were cultured with target cells coated with 
thyroglobulin (200 yg/ml.). A cytotoxic index of 22.6 was obtained 
for the thyroiditis patient compared to 9.7 for the control subject. 
Calder et al. (1973) found a mean cytotoxic index of 25.46 + 3.8 for 
lymphocytes taken from a patient with Hashimoto’s thyroiditis and a 
mean index of 6.28+0.80 for control lymphocytes.
K-cell Cytotoxicity. In order to determine the optimal concentration 
of rabbit anti-chicken red cell serum, an initial experiment was
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Fig. 8.2. K-cell cytotoxicity dose-response curve. Specific release of 
sodium 5lcr-chromate from chicken erythocytes cultured with 
lyaxphocytes from a control subject in the presence oJ varying 
dilutions of rabbit anti-chicken red cell serum in a volume 
of 0.25 ml.
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performed using lymphocytes from a control subject and rabbit anti­
chicken red cell serum, in 0.25 ml. aliquots, in the following dilu­
tions, 1/100, 1/1000, 1/10000, 1/100000. Figure 8.2 shows the dose- 
response curve obtained. The optimum dilutions of rabbit anti­
chicken red cell serum for K-cell cytotoxicity are seen to be 1/1000 
and 1/10000 and these were used in the experiments described.
Table 8.2 shows the specific release of sodium ^^Cr-chromate 
elicited by lymphocytes from the 17 insulin-dependent diabetics and 
the 17 control subjects at two dilutions of antiserum. Depression of 
K-cell cytotoxicity was seen in the diabetic lymphocytes compared to 
control lymphocytes in experiments 1, 2, 5, 7, 13, and 14. K-cell 
cytotoxic activity of the diabetic patients was depressed by at 
least 5% when expressed as specific release of chromium. Four of 
these patients showed a depression of at least 10%.
When the mean specific release was considered, the diabetic pa­
tients* lymphocytes showed a decrease of 5.3% compared to the control 
subjects* lymphocytes at an antiserum dilution of 1/1000. At a dilu­
tion of 1/10000 a decrease of 1.5% was observed.
Discussion
T-cell Cytotoxicity. In this series of experiments the figures for 
spontaneous release and maximum release corresponded to those re­
ported by other investigators. Calder et al. (1973) found spontane­
ous release to be between 2% and 15%, whilst maximum release after 
20 hours was between 70% and 87%. Podleski (1972) found that coat­
ing the cells increased spontaneous release. Thus, he obtained a 
figure of 20.88% for coated cells and a figure of 17.44% for uncoated 
cells. Holm and Perlmann (1967) found spontaneous release to be
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approximately 25% after 24 hours, although they were using target
cells other than chicken red cells which were used here. Perlmann
and Holm (1969) stated that under optimal conditions spontaneous re- 
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lease of sodium Cr-chromate from chicken erythocytes does not ex­
ceed 5% in 24 hours. Perlmann et al. (1970), using chicken erythro­
cytes as target cells found spontaneous release to be between 10% 
and 15% usually and never exceeding 20%. They stated that this leak­
age was due to tannic acid treatment. In the experiments presented 
here spontaneous release was usually approximately 10% and maximum 
release was between 70% and 80%.
When the cytotoxic indices obtained with lymphocytes from 
diabetic patients were compared to those from lymphocytes from con­
trol subjects, there were only 2/13 that showed an increase. This is 
not in keeping with other parameters of T-cell function in diabetes 
where there is considerable evidence of cell-mediated hypersensitiv­
ity using the leucocyte migration inhibition test with the same anti­
gens. To a lesser degree T-cell function, examined by means of lym­
phocyte transformation using PHA, has also shown a disturbance. In 
addition, of the two patients showing increased cytotoxic activity, 
one was newly diagnosed, whilst the other had developed diabetes 6 
years previously. It would be expected that greater cell-mediated 
activity directed against pancreatic antigens would be more apparent 
during the active stage of the disease process, i.e., prior to or at 
the onset of diabetes. The results presented here militate against 
the involvement of T-cell cytotoxic activity in the majority of dia­
betics. However, only a small number of subjects were tested and 
these were examined at various times after the diagnosis of diabetes. 
To get a better idea of cytotoxic T-cell activity patients should be
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tested immediately after diagnosis once their condition is stabil­
ised to exclude any metabolic inhibition of lymphocyte activity. 
Also, the ideal target cell would be cultured islet cells labelled 
with a radioisotope. Insulinoma cells would also be preferable, but 
it is possible that their antigenicity may be different than that of 
the non-malignant islet cell. Alternatively, islet cell homogenates 
could be used to coat the cells in the manner described here. In 
the experiments performed here pancreatic homogenate was used which 
consists of only 1% islet tissue. Consequently, it is possible that 
not all the target cells were coated with the relevant islet cell 
antigen.
That this system is reproducible would appear to be borne 
out by the experiment performed using lymphocytes obtained from a 
patient with Hashimoto's thyroiditis. The cytotoxic indices ob­
tained closely agreed with the mean indices reported by Calder et 
al. (1973). They found a cytotoxic index of 25.46 and 6.28 for the 
thyroiditis patient and control subject, respectively, which com­
pare favourably with the values of 22.6 and 9.7, respectively, which 
were found here.
K-cell Cytotoxicity. Of the diabetic patients tested, 6/17 showed 
a depression in cytotoxic lymphocyte activity of at least 5% when 
compared to control subjects. However, increases in cytotoxic 
activity were found in some patients, 12 and 15. The largest de­
creases were found in patients 1, 2, 5, and 7, and this may reflect 
a depression of K-cell cytotoxic activity in these patients. It 
could, however, be indicative of a reduced number of K-cells which, 
in effect, would amount to the same result. In these studies
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lymphocytes were counted with no differentiation of the various dif­
ferent types.
To clarify the situation with respect to the two different 
dilutions of antiserum, mean values for specific release were used. 
This then takes into account the fact that the optimal activity of 
one set of lymphocytes might be at a 1/1000 dilution of antiserum, 
whilst in another set the optimal activity may be at a dilution of 
1/10000 or somewhere between the two. Patients showing an overall 
decrease of at least 5% were 1, 2, 5, 7, 8, 13, 14, whilst those show­
ing an increase were 12 and 15. The mean depression for patients 
1, 2, 5, and 7 were 18.8%, 13.6%, 13.4%, and 13.1%, respectively.
Ludwig et al. (1977) found K-cell cytotoxicity depressed in 3 
patients from a group of 35 insulin-dependent diabetics. Here 4 
diabetics from 17 were depressed by over 10% when compared directly 
to their own control. Ludwig et al. (1977) concluded that K-cell 
cytotoxicity did not play a major role in the pathogenesis of dia­
betes mellitus or that any deficiency was responsible for the lack of 
immunity found in subjects with this disease. It is known that anti- 
body-dependent cell-mediated cytotoxicity due to non-immune Fc re­
ceptor bearing "killer” cells is important in the destruction of 
bacteria, viruses and tumours and may be of importance in the patho­
genesis of autoimmune diseases. From the preliminary results pre­
sented here, there is an overall decrease in cytotoxic activity of 
diabetic lymphocytes as shown by the means. In 4 cases there is a 
substantial decrease. These results lead to the suggestion that de­
ficiency of this system may well be involved, at least in part, by 
the lack of defence against infection seen in insulin-dependent dia­
betics. With respect to the pathogenesis of diabetes mellitus.
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conclusions are more difficult. If K-cell cytotoxicity is directly 
involved, then an increased activity would be anticipated in newly 
diagnosed diabetes. However, if islet cell damage is the direct re­
sult of a viral assault, which later leads to autoimmune manifesta­
tions, then depression of K-cell cytotoxicity could be implicated by 
virtue of the fact that the patient would be more susceptible and 
less capable of destroying the virus.
Further experiments need to be performed using newly diagnosed 
type I diabetics, long-term type I diabetics, type II diabetics, and 
control subjects. In each case a complete dose-response curve for 
differing dilutions of antiserum needs to be carried out.
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CHAPTER IX.
Discussion.
The work presented here, ip conjunction with other studies that 
have been described, does not permit any firm conclusions to be drawn 
with regard to the aetiology of insulin-dependent diabetes mellitus.
The parameters measured, for the study of immunologic processes 
that may be involved, confirm the results of other investigators. 
Cell-mediated hypersensitivity, assessed by the leucocyte migration 
inhibition test, has been seen to occur against pancreatic fractions, 
and rat liver mitochondria which is regarded as a general manifesta­
tion of autoimmune disease (MacCuish et al., 1974a). The presence of 
autoantibodies in insulin-dependent diabetes has also been shown and 
this is in accordance with the results of other investigators (Bot- 
tazzo et al., 1974; Nerup et al., 1974; MacCuish et al., 1974). How­
ever, the role of islet cell antibody remains to be elucidated as it
reacts with other cells of the islets as well as beta cell and results
in strictly intracytoplasmic staining. Consequently, their involve­
ment in the pathogenesis of diabetes is difficult to conceive 
(Kaldany, 1979). Antibody production is more likely to be the re­
sult of islet cell damage or, perhaps, as Irvine et al. (1976) sug­
gest, a marker for asymptomatic, latent diabetes. In contrast, 
MacLaren et al. (1975) have found a cell surface binding antibody to 
cultured human insulinoma cells in the majority of insulin-dependent 
diabetics, and recently Lernmark et al. (1978) have demonstrated an
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islet cell membrane antibody in the serum of patients with newly diag­
nosed disease. A possible role of islet cell surface binding anti­
bodies in diabetes may be in initiating antibody-dependent cell- 
mediated cytotoxic reactions leading to islet cell damage. The re­
lationship between the antibodies discovered by Bottazzo et al. (1974), 
MacLaren et al. (1975), and Lernmark et al. (1978) is not known.
Further disturbances in immune processes were not found to any 
great extent. Depression of lymphocyte transformation due to PHA was 
found in only 2/10 patients tested and this effect may have been the 
result of metabolic disturbances as suggested by MacCuish et al.
(1974b) as opposed to an inherent immune defect implied by Brody and 
Merlie (1970). In addition, depression of K-cell cytotoxicity was 
observed in some insulin-dependent diabetics studied in this project, 
and this may, in part, be responsible for the lack of resistance 
against infection found in these patients.
If these effects are the result of metabolic disturbance rather 
than an immune defect, they provide an explanation for the lack of 
resistance to infection. If, however, this susceptibility to infec­
tion is due to an inherent immune defect, then there is a greater 
possibility of pancreotropic viral agents mediating islet cell dam­
age and leading to diabetes. Had K-cell cytoxic activity been in­
creased in diabetes, a role could be found for surface binding auto­
antibody of the IgG class in mediating antibody-dependent cell- 
mediated cytotoxicity. Viruses could still be implicated by postu­
lating that damage to the islets or altered surface antigenic deter­
minants may lead to the production of an autccntibody which, in turn, 
leads to K-cell destruction of the cells.
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From most of the studies performed a cell-mediated effect seems 
to be the most likely to be involved in the pathogenesis of diabetes, 
but the results of the T-cell cytotoxicity experiments performed 
here revealed no further information. This is not in accordance with 
previous tests of leucocyte migration where a cell-mediated reaction 
was seen using the same pancreatic fractions. Possible reasons for 
this have been discussed in Chapter VIII.
Evidence for the involvement of viruses in the aetiology of
diabetes mellitus have not been confirmed in the study using mice. 
Many investigators have shown that viruses can induce diabetes in
mice (From et al., 1968; Craighead and McLane, 1968; Craighead and
Steinke, 1971; Coleman et al., 1973). However, the use of an outbred 
strain of CD^ mice may be responsible for the lack of susceptibility 
to Coxsackie virus. As discussed previously, it is possible that 
viruses may initiate the disease in man through an autoimmune re­
sponse. Had the mice developed diabetes mellitus, the involvement of 
the immune system could have been assessed by selectively depressing 
cell-mediated and humoral components of this system. In addition, 
similar tests of immune function could have been carried out such as 
migration inhibition and cytotoxicity tests.
In the clinical studies performed there is evidence for viral 
involvement. It has been shown that a greater percentage of insulin- 
dependent diabetic patients possess cell-mediated hypersensitivity to 
Coxsackie B^ virus than either insulin-indepedent diabetics or con­
trol subjects. Further support for viral involvement has been pro­
vided by the recuits of absorption studies with islet cell antibody 
positive sera from diabetic patients where the intensity of fluore­
scence was reduced. Additional evidence, albeit circumstantial, is
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provided by the finding of a seasonal incidence which has been shown 
previously (Gamble and Taylor, 1969).
The studies on the histocompatibility system have confirmed the 
increased frequency of HLA-B8 and B15 in insulin-dependent diabetic 
subjects and also the protective effect of HLA-B7. Other studies of 
the HLA system by various investigators have revealed the existence 
of genetic heterogeneity reviewed by Cudworth (1978). Herein lies a 
major difficulty in investigating a disease such as diabetes melli­
tus in that, in its clinically recognised form, it probably repre­
sents several similar conditions having different causes and patho­
genetic mechanisms (Rotter and Rimoin, 1978). Most investigations 
have used insulin-dependent diabetics as one group, whereas various 
subgroups which are aetiologically distinct may have been included. 
For example, according to Irvine * s (1977) classification, types I and 
II are both insulin-dependent and type I is further subdivided accord­
ing to pathogenesis whether it be of a viral or autoimmune nature or 
both. If all the various possible subgroups are included in one 
group when investigative procedures are carried out, then it would be 
difficult to determine the environmental precipating factors. Ac­
cording to Cudworth (1978) any investigation into the aetiology or 
pathogenesis of diabetes should first consider the role of genetic 
determination and then elucidate how this susceptibility is exploited 
by environmental factors.
That the disease is associated with the HLA system is evidence 
for immunopathologic mechanisms occurring as an isolated incident or 
more probably as initiated by a sensitising effect by viral or chemi­
cal agents (Craighead, 1978). Also, that the disease is associated 
with HLA-B8, which is found in a number of other autoimmune diseases.
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is evidence for an immune component in many patients. It is likely 
that genes on the sixth chromosome affect immunologic responsiveness, 
and it has been suggested that HLA antigens on the plasma membrane of 
beta cells may serve as receptors for viruses and possibly chemicals. 
Like and Rossine (1976) have shown that mice develop diabetes which 
is associated with insulinitis and P-cell degranulation when re­
peatedly given subdiabetogenic doses of streptozotocin. This sug­
gests that subtle chemical injury may result in immunologic sensi­
tisation.
In conclusion, it is attractive to speculate that immune re­
sponse genes associated with the HLA system confer susceptibility or 
protectiveness to certain viruses which have a potential affinity 
for the islet cells, particularly the 3-cells. The damage effected 
by these viruses may lead to an immunologic response due to the re­
lease of sequestered antigens or by changing cell surface antigen 
determinants. Therefore, it is possible that the immune system re­
sults in damage after the initiating viral attack. Alternatively, 
susceptibility to viruses conferred by immune response genes may 
lead to direct and irreversible effects on the islet cells leading 
to the clinical manifestations of insulin-dependent diabetes melli­
tus.
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